<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">F1000Res</journal-id>
<journal-id journal-id-type="iso-abbrev">F1000Res</journal-id>
<journal-id journal-id-type="pmc">F1000Research</journal-id>
<journal-title-group>
<journal-title>F1000Research</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-1402</issn>
<publisher>
<publisher-name>F1000Research</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26594346</article-id>
<article-id pub-id-type="pmc">4648203</article-id>
<article-id pub-id-type="doi">10.12688/f1000research.6938.1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group>
<subject>Articles</subject>
<subj-group>
<subject>Epidemiology</subject>
</subj-group>
<subj-group>
<subject>Genomics</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Repository of mutations from Oman: The entry point to a national mutation database</article-title>
<fn-group content-type="pub-status">
<fn>
<p>[version 1; referees: 2 approved]</p>
</fn>
</fn-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rajab</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="corresp" rid="c1">a</xref>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hamza</surname>
<given-names>Nishath</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al Harasi</surname>
<given-names>Salma</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al Lawati</surname>
<given-names>Fatma</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gibbons</surname>
<given-names>Una</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al Alawi</surname>
<given-names>Intesar</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kobus</surname>
<given-names>Karoline</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hassan</surname>
<given-names>Suha</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mahir</surname>
<given-names>Ghariba</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al Salmi</surname>
<given-names>Qasim</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mons</surname>
<given-names>Barend</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Robinson</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<aff id="a1">
<label>1</label>National Genetic Center, Ministry of Health, Muscat, PC 111, Oman</aff>
<aff id="a2">
<label>2</label>Royal Hospital, Ministry of Health, Muscat, PC 111, Oman</aff>
<aff id="a3">
<label>3</label>Bio-Semantics at the Department of Medical Informatics, Erasmus Medical Centre, University of Rotterdam, Rotterdam, 3015 CE, Netherlands</aff>
<aff id="a4">
<label>4</label>Institute of Medical Genetics and Human Genetics, Berlin, 13353, Germany</aff>
</contrib-group>
<author-notes>
<corresp id="c1">
<label>a</label>
<email xlink:href="mailto:drannarajab@gmail.com">drannarajab@gmail.com</email>
</corresp>
<fn fn-type="con">
<p>RA and MB conceived the study. RA prepared the first draft of the manuscript. RA, AHS, ALF, GU, MH, HS and ASQ carried out the research. HN, AI, KK, MB and RP contributed to the preparation of the manuscript. All authors were involved in the revision of the draft.</p>
</fn>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests: </bold>The authors declared no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>4</volume>
<elocation-id>891</elocation-id>
<history>
<date date-type="accepted">
<day>11</day>
<month>9</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2015 Rajab A et al.</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="f1000research-4-7471.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>The Sultanate of Oman is a rapidly developing Muslim country with well-organized government-funded health care services, and expanding medical genetic facilities. The preservation of tribal structures within the Omani population coupled with geographical isolation has produced unique patterns of rare mutations. In order to provide diagnosticians and researchers with access to an up-to-date resource that will assist them in their daily practice we collated and analyzed all of the Mendelian disease-associated mutations identified in the Omani population. By the 1
<sup>st</sup> of August 2015, the dataset contained 300 mutations detected in over 150 different genes. More than half of the data collected reflect novel genetic variations that were first described in the Omani population, and most disorders with known mutations are inherited in an autosomal recessive fashion. A number of novel Mendelian disease genes have been discovered in Omani nationals, and the corresponding mutations are included here. The current study provides a comprehensive resource of the mutations in the Omani population published in scientific literature or reported through service provision that will be useful for genetic care in Oman and will be a starting point for variation databases as next-generation sequencing technologies are introduced into genetic medicine in Oman.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Genetic Disease</kwd>
<kwd>Birth Defects</kwd>
<kwd>disease-associated mutation data</kwd>
<kwd>Sultanate of Oman</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that no funding was involved in supporting this work.</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Oman is situated in the South East of the Arabian Peninsula along the East coast of the Arabian Gulf (
<xref ref-type="fig" rid="f1">Figure 1</xref>). It has its borders with United Arab Emirates to the North, Saudi Arabia to the West and Yemen to the South West. Oman is the second largest territory in the Arabian Peninsula with an area of 82,000 square miles and a coastline length of 1,300 miles. The native Omani population comprises around 2.2 million inhabitants, and the rate of annual population increase is approximately 25 per 1000. Oman has a young population with nearly half of the population being under 15 years. The Omani population is characterized by a high growth rate, large family size, consanguineous marriages, and the presence of genetic isolates.</p>
<fig fig-type="figure" id="f1" orientation="portrait" position="float">
<label>Figure 1. </label>
<caption>
<title>Oman is situated in the South East of the Arabian Peninsula along the East coast of the Arabian Gulf.</title>
</caption>
<graphic xlink:href="f1000research-4-7471-g0000"></graphic>
</fig>
<p>Clinical genetic services were introduced in the Sultanate of Oman in the past decade and they have become an important component of health care. This greatly facilitated the systematic collection of data on genetic diseases and birth defects in the past few decades. With the inauguration of the National Genetic Center in 2013, the existing clinical genetic services were supplemented by sophisticated genetic laboratory services.</p>
<p>The amount of published data available on genetic disorders in the Sultanate is considerable. There were a few previous attempts to list the genetic diseases reported in Oman
<sup><xref ref-type="bibr" rid="ref-1">1</xref>–
<xref ref-type="bibr" rid="ref-4">4</xref></sup> and to link them to specific population groups and geographic locations
<sup><xref ref-type="bibr" rid="ref-5">5</xref>,
<xref ref-type="bibr" rid="ref-6">6</xref></sup>, analyze population structure
<sup><xref ref-type="bibr" rid="ref-7">7</xref></sup>, and to estimate the impact of genetic disorders and birth defects on the community
<sup><xref ref-type="bibr" rid="ref-4">4</xref></sup> and summarize the genetic services available
<sup><xref ref-type="bibr" rid="ref-8">8</xref></sup>. The advances in bioinformatics required to annotate human genomic variants and to place them in public data repositories have not kept pace with their discovery. The deposition of such data in the public domain is essential to maximize both their scientific and clinical utility
<sup><xref ref-type="bibr" rid="ref-9">9</xref></sup>.</p>
<p>Hence, in the current study we present a comprehensive compilation of germline mutations in nuclear genes associated with human disease in the Omani population.</p>
</sec>
<sec sec-type="materials | methods">
<title>Materials and methods</title>
<p>The wealth of genetic variant data in Omani nationals was collected from multiple sources which form a basis for research into genetic conditions reported from Oman. Multiple sources of data were reviewed to form repository of mutations in Omani nationals introduced in this paper. The sources of data included:</p>
<p>(1) 1993–2015 records of patients consulted by clinical geneticists of the Royal Hospital, the largest tertiary hospital in Oman;</p>
<p>(2) 2008–2015 publications curated from PUBMED on birth defects and genetic conditions in Omani nationals. The keywords used were: “Oman”, “Genetic disorders”, “Birth defects”, “mutations”;</p>
<p>(3) 2012–2014 commercial laboratories referral registry at the Royal Hospital for the samples tested overseas.</p>
<p>(4) The internal genetic variant repository of the National Genetic Center &lt;&lt;
<ext-link ext-link-type="uri" xlink:href="HTTP://ogvd.net">HTTP://ogvd.net</ext-link>&gt;&gt;;</p>
<p>The data presented in this article was manually curated. The OMIM identifiers, Phenotype MIM accession numbers, Phenotype name (OMIM), mutation descriptions, and relevant publications with PMID numbers were all collected from the NCBI database repository. All unavailable through PubMed mutation details were checked with ClinVar, LOVD and CentoMD. The details of unpublished mutations are not included in the present study and feature in
<xref ref-type="table" rid="T2">Table 2</xref> as “Novel mutations”.</p>
</sec>
<sec sec-type="results">
<title>Results</title>
<p>In this study, a wide range of genetic conditions with known mutations collected in Omani nationals were analysed. The disease classifications are comprised of 44 gene variants causing neurodevelopmental disorders, 21 inborn errors of metabolism, 13 endocrinopathies, 15 skeletal dysplasias, nine disorders of the immune system, four hereditary blood disorders as well as other National groups (
<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" orientation="portrait" position="anchor">
<label>Table 1. </label>
<caption>
<title>Range of genetic conditions with known mutations in Omani nationals (details presented in
<xref ref-type="table" rid="T2">Table 2</xref> and
<xref ref-type="table" rid="T3">Table 3</xref>).</title>
</caption>
<table content-type="article-table" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Range of Genetic Conditions with
<break></break>known mutations in Omani nationals</th>
<th align="left" colspan="1" rowspan="1" valign="top">Number
<break></break>of disease
<break></break>causing genes</th>
<th align="left" colspan="1" rowspan="1" valign="top">Number
<break></break>of disease
<break></break>causing
<break></break>mutations</th>
<th align="left" colspan="1" rowspan="1" valign="top">Novel
<break></break>Mutations of
<break></break>known genes</th>
<th align="left" colspan="1" rowspan="1" valign="top">Novel genes
<break></break>and novel
<break></break>genetic
<break></break>mechanisms</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Genetic Blood Disorders</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">              Beta-Globin</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">33</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">              Alpha-Globin</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">22</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">              Delta-Globin</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">14</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">Other hemolytic and hemorrhagic disorders</td>
<td colspan="1" rowspan="1" valign="top">3</td>
<td colspan="1" rowspan="1" valign="top">5</td>
<td colspan="1" rowspan="1" valign="top">3</td>
<td colspan="1" rowspan="1" valign="top">2</td>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Neurodevelopmental disorders</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
</tr>
<tr>
<td colspan="1" rowspan="1">         Conditions with intellectual disability</td>
<td colspan="1" rowspan="1">20</td>
<td colspan="1" rowspan="1">23</td>
<td colspan="1" rowspan="1">9</td>
<td colspan="1" rowspan="1">7</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Primary Microcephaly</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Epileptic syndromes</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Neurodegenerative conditions</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Syndromic ciliopathies</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hereditary spastic paraplegias</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">4</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Neuropathies and neuromuscular
<break></break>disorders</td>
<td colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Arthrogryposis</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Inborn errors of metabolism</td>
<td colspan="1" rowspan="1">21</td>
<td colspan="1" rowspan="1">28</td>
<td colspan="1" rowspan="1">21</td>
<td colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Endocrine disorders</td>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">28</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">5</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Intrahepatic cholestasis and gut anomalies</td>
<td colspan="1" rowspan="1">4</td>
<td colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Disorders of the immune system</td>
<td colspan="1" rowspan="1">9</td>
<td colspan="1" rowspan="1">15</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Familial cancers</td>
<td colspan="1" rowspan="1">4</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Skeletal dysplasias and osteodysplasias</td>
<td colspan="1" rowspan="1">15</td>
<td colspan="1" rowspan="1">23</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cardiogenetic conditions</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Renal disorders and dysplasias</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Skin, nails, and hair disorders</td>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">10</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cutis laxa syndromes</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1" valign="top">Ophthalmological diseases including
<break></break>blindness</td>
<td colspan="1" rowspan="1" valign="top">5</td>
<td colspan="1" rowspan="1" valign="top">8</td>
<td colspan="1" rowspan="1" valign="top">0</td>
<td colspan="1" rowspan="1" valign="top">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Congenital deafness</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Congenital lipodystrophies</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">0</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cystic fibrosis</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">4</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<bold>Total</bold>
</td>
<td colspan="1" rowspan="1">
<bold>156</bold>
</td>
<td colspan="1" rowspan="1">
<bold>300</bold>
</td>
<td colspan="1" rowspan="1">
<bold>83</bold>
</td>
<td colspan="1" rowspan="1">
<bold>58</bold>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Extensive genetic studies were performed in Oman for Genetic Blood Disorders and various conditions leading to intellectual disabilities, mental and physical handicap.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In total more than 150 rare genetic disorders were listed in
<xref ref-type="table" rid="T2">Table 2</xref> and
<xref ref-type="table" rid="T3">Table 3</xref> with relevant OMIM numbers, PubMed ID (PMID), Gene/Locus name, nucleotide(s) change(s) and the source of the data (PubMed ID Number/ OMIM/ClinVar/LOVD/CentoMD). The names of genetic conditions in
<xref ref-type="table" rid="T2">Table 2</xref> are stated as found in OMIM “Phenotype-Gene Relationships” table as “Phenotype” arranged in alphabetical order. In
<xref ref-type="table" rid="T3">Table 3</xref>, we present a separate list of 69 known mutations (11–15) that were collected through service provision at the Hemoglobinopathy Laboratory at the National Genetic Center in Oman.</p>
<table-wrap id="T2" orientation="portrait" position="anchor">
<label>Table 2. </label>
<caption>
<title>List of disease-associated mutations in Omani nationals.</title>
</caption>
<table content-type="article-table" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">No.</th>
<th align="left" colspan="1" rowspan="1" valign="top">Phenotype (OMIM)</th>
<th align="left" colspan="1" rowspan="1" valign="top">OMIM</th>
<th align="left" colspan="1" rowspan="1" valign="top">PMIM ID</th>
<th align="left" colspan="1" rowspan="1" valign="top">Gene/Locus</th>
<th align="left" colspan="1" rowspan="1" valign="top">Nucleotide change</th>
<th align="left" colspan="1" rowspan="1" valign="top">Source:
<break></break>Pubmed ID Nos/
<break></break>Registration at
<break></break>international
<break></break>databases</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="2">1</td>
<td colspan="1" rowspan="2">Achondroplasia</td>
<td align="left" colspan="1" rowspan="2">100800</td>
<td align="left" colspan="1" rowspan="2">134934</td>
<td align="left" colspan="1" rowspan="2">FGFR3</td>
<td align="left" colspan="1" rowspan="1">c.749G&gt;C;</td>
<td align="left" colspan="1" rowspan="2">LOVD</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1172C&gt;A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="5">2</td>
<td colspan="1" rowspan="5">Adrenal hyperplasia, congenital, due
<break></break>to 21-hydroxylase deficiency</td>
<td align="left" colspan="1" rowspan="5">201910</td>
<td align="left" colspan="1" rowspan="5">613815</td>
<td align="left" colspan="1" rowspan="5">CYP 21A2</td>
<td align="left" colspan="1" rowspan="1">p.I236N</td>
<td align="left" colspan="1" rowspan="5">21274396</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p.V237E</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p.M239K</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c. 306T insert,</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p.Q318X; conv Cyp 21P
<break></break>to Cyp 21A2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">Adrenal hyperplasia, congenital, due
<break></break>to 17-hydroxylase deficiency</td>
<td align="left" colspan="1" rowspan="1">202110</td>
<td align="left" colspan="1" rowspan="1">609300</td>
<td align="left" colspan="1" rowspan="1">CYP17A1</td>
<td align="left" colspan="1" rowspan="1">c.287G&gt;A
<break></break>p.Arg96Gln</td>
<td align="left" colspan="1" rowspan="1">24498484</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">4</td>
<td colspan="1" rowspan="2">Allopecia universalis congenita</td>
<td align="left" colspan="1" rowspan="2">*203655</td>
<td align="left" colspan="1" rowspan="2">602302</td>
<td align="left" colspan="1" rowspan="2">HR</td>
<td align="left" colspan="1" rowspan="1">c. 2776+1, G&gt;A</td>
<td align="left" colspan="1" rowspan="2">9736769</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1022T&gt;A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">5</td>
<td colspan="1" rowspan="2">Alport syndrome, autosomal dominant</td>
<td align="left" colspan="1" rowspan="2">104199</td>
<td align="left" colspan="1" rowspan="2">104200</td>
<td align="left" colspan="1" rowspan="2">COL4A3</td>
<td align="left" colspan="1" rowspan="1">c.479G&gt;A;</td>
<td align="left" colspan="1" rowspan="2">14871398</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.232delG</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">Alport syndrome, autosomal recessive</td>
<td align="left" colspan="1" rowspan="1">203780</td>
<td align="left" colspan="1" rowspan="1">120070</td>
<td align="left" colspan="1" rowspan="1">COL4A3</td>
<td align="left" colspan="1" rowspan="1">R1215X(CGA&gt;TG</td>
<td align="left" colspan="1" rowspan="1">14582039</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">7</td>
<td colspan="1" rowspan="2">Alport syndrome, X-linked (ATS)</td>
<td align="left" colspan="1" rowspan="2">301050</td>
<td align="left" colspan="1" rowspan="2">303630</td>
<td align="left" colspan="1" rowspan="2">COL 4A5</td>
<td align="left" colspan="1" rowspan="1">del exons 7–8 and
<break></break>31–36</td>
<td align="left" colspan="1" rowspan="2">25333070
<break></break>15149316</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">potential duplication
<break></break>of exons 21 – 30+/-
<break></break>exon 20</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">Alstrom syndrome</td>
<td align="left" colspan="1" rowspan="1">*606884</td>
<td align="left" colspan="1" rowspan="1">203800</td>
<td align="left" colspan="1" rowspan="1">ALMS1</td>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
<td align="left" colspan="1" rowspan="1">17594715</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">9</td>
<td colspan="1" rowspan="3">Amelogenesis imperfecta, type IIA3</td>
<td align="left" colspan="1" rowspan="3">*613211</td>
<td align="left" colspan="1" rowspan="3">613214</td>
<td align="left" colspan="1" rowspan="3">WDR72</td>
<td align="left" colspan="1" rowspan="1">c.978T-to-ter</td>
<td align="left" colspan="1" rowspan="3">19853237</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">(V968X);</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2857delA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="6">10</td>
<td colspan="1" rowspan="6">Apparent Mineralocorticoid
<break></break>excess (AME 1);Cortisol 11-beta-
<break></break>ketoreductase deficiency</td>
<td align="left" colspan="1" rowspan="6">*218030</td>
<td align="left" colspan="1" rowspan="6">614232</td>
<td align="left" colspan="1" rowspan="6">HSD11B2</td>
<td align="left" colspan="1" rowspan="1">Exon 1: R74G ;</td>
<td align="left" colspan="1" rowspan="6">15134813</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pdelta1nt</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">(P75Delta1nt)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exon2: L114Delta6nt</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exon 5: V322ins9nt</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exon 3 :A221V</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">11</td>
<td colspan="1" rowspan="1">Arterial tortuosity syndrome</td>
<td align="left" colspan="1" rowspan="1">208050</td>
<td align="left" colspan="1" rowspan="1">208050</td>
<td align="left" colspan="1" rowspan="1">SLC2A10</td>
<td align="left" colspan="1" rowspan="1">243C-G</td>
<td align="left" colspan="1" rowspan="1">16550171</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">12</td>
<td colspan="1" rowspan="1">Arthrogryposis, renal dysfunction, and
<break></break>cholestasis 1</td>
<td align="left" colspan="1" rowspan="1">*608552</td>
<td align="left" colspan="1" rowspan="1">208085</td>
<td align="left" colspan="1" rowspan="1">Vps33B</td>
<td align="left" colspan="1" rowspan="1">c.350delC</td>
<td align="left" colspan="1" rowspan="1">15052268</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">Autoimmune Lymphoproliferative
<break></break>Syndrome (Type A)</td>
<td align="left" colspan="1" rowspan="1">601859</td>
<td align="left" colspan="1" rowspan="1">601853</td>
<td align="left" colspan="1" rowspan="1">FAS</td>
<td align="left" colspan="1" rowspan="1">c.232 del G, exon3</td>
<td align="left" colspan="1" rowspan="1">8787672</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">14</td>
<td colspan="1" rowspan="1">Bardet-Biedl Syndrome 9 (BBS9)</td>
<td align="left" colspan="1" rowspan="1">*615986</td>
<td align="left" colspan="1" rowspan="1">615986</td>
<td align="left" colspan="1" rowspan="1">PTHB1</td>
<td align="left" colspan="1" rowspan="1">IVS 17/IGTA variant</td>
<td align="left" colspan="1" rowspan="1">17106446</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">15</td>
<td colspan="1" rowspan="2">Bardet-Biedl Syndrome 10 (BBS10)</td>
<td align="left" colspan="1" rowspan="2">*209900</td>
<td align="left" colspan="1" rowspan="2">209900</td>
<td align="left" colspan="1" rowspan="2">FLJ23560</td>
<td align="left" colspan="1" rowspan="1">n.364fsX368</td>
<td align="left" colspan="1" rowspan="2">17106446</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FLJ 23560</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">16</td>
<td colspan="1" rowspan="1">Brain Calcifications/Coat’s like
<break></break>syndrome/Rajab syndrome</td>
<td align="left" colspan="1" rowspan="1">*613658</td>
<td align="left" colspan="1" rowspan="1">613658</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Linkage to 2q36.3</td>
<td align="left" colspan="1" rowspan="1">19161147</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">17</td>
<td colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">114480</td>
<td align="left" colspan="1" rowspan="1">114480</td>
<td align="left" colspan="1" rowspan="1">BRCA 1</td>
<td align="left" colspan="1" rowspan="1">2080insA</td>
<td align="left" colspan="1" rowspan="1">18340530</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">18</td>
<td colspan="1" rowspan="1">Carbamoylphosphate synthetase I
<break></break>deficiency</td>
<td align="left" colspan="1" rowspan="1">*238970</td>
<td align="left" colspan="1" rowspan="1">237300</td>
<td align="left" colspan="1" rowspan="1">CPSI</td>
<td align="left" colspan="1" rowspan="1">c.1590dupT</td>
<td align="left" colspan="1" rowspan="1">22106832</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">19</td>
<td colspan="1" rowspan="1">Carnitinepalmitoyl carboxylase
<break></break>deficiency</td>
<td align="left" colspan="1" rowspan="1">*600650</td>
<td align="left" colspan="1" rowspan="1">1p32.3</td>
<td align="left" colspan="1" rowspan="1">CPT2 gene</td>
<td align="left" colspan="1" rowspan="1">detectable mutations
<break></break>were excluded</td>
<td align="left" colspan="1" rowspan="1">ClinVar</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">20</td>
<td colspan="1" rowspan="2">Central hypoventilation syndrome,
<break></break>congenital</td>
<td align="left" colspan="1" rowspan="2">603851</td>
<td align="left" colspan="1" rowspan="2">209880</td>
<td align="left" colspan="1" rowspan="2">PHOX2B</td>
<td align="left" colspan="1" rowspan="1">5 Alanine Expansions</td>
<td align="left" colspan="1" rowspan="2">ClinVar</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">10 Alanine expansions</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21</td>
<td colspan="1" rowspan="1">Ceroid lipofuscinosis, neuronal,
<break></break>2 (CLN2)</td>
<td align="left" colspan="1" rowspan="1">*204500</td>
<td align="left" colspan="1" rowspan="1">607998</td>
<td align="left" colspan="1" rowspan="1">TPP1</td>
<td align="left" colspan="1" rowspan="1">positive linkage</td>
<td align="left" colspan="1" rowspan="1">17690061</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">22</td>
<td colspan="1" rowspan="1">Charcot-Marie-Tooth disease, type 4A</td>
<td align="left" colspan="1" rowspan="1">214400</td>
<td align="left" colspan="1" rowspan="1">214400</td>
<td align="left" colspan="1" rowspan="1">GDAP1</td>
<td align="left" colspan="1" rowspan="1">Start-codon mutation</td>
<td align="left" colspan="1" rowspan="1">22200116</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td colspan="1" rowspan="1">Cohen Syndrome (COH 1)</td>
<td align="left" colspan="1" rowspan="1">*216550</td>
<td align="left" colspan="1" rowspan="1">216550</td>
<td align="left" colspan="1" rowspan="1">VPS13B</td>
<td align="left" colspan="1" rowspan="1">7934G&gt;A</td>
<td align="left" colspan="1" rowspan="1">15173253</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4">24</td>
<td colspan="1" rowspan="4">Cystic Fibrosis</td>
<td align="left" colspan="1" rowspan="4">*219700</td>
<td align="left" colspan="1" rowspan="4">7q31.2</td>
<td align="left" colspan="1" rowspan="4">CFTR</td>
<td align="left" colspan="1" rowspan="1">102T&gt;A+S549R(T&gt;G)]</td>
<td align="left" colspan="1" rowspan="4">25829996;
<break></break>10480369</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">delta F508</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">F208Del;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">S549Rdel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">25</td>
<td colspan="1" rowspan="1">Cholestasis intrahepatic</td>
<td align="left" colspan="1" rowspan="1">*243300</td>
<td align="left" colspan="1" rowspan="1">243300</td>
<td align="left" colspan="1" rowspan="1">ATP8B1</td>
<td align="left" colspan="1" rowspan="1">(exon 15) het del</td>
<td align="left" colspan="1" rowspan="1">CentoMD;
<break></break>15239083</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">26</td>
<td colspan="1" rowspan="2">Cholestasis, benign recurrent
<break></break>intrahepatic, 2</td>
<td align="left" colspan="1" rowspan="2">605479</td>
<td align="left" colspan="1" rowspan="2">605479</td>
<td align="left" colspan="1" rowspan="2">ABCB11</td>
<td align="left" colspan="1" rowspan="1">c.149G.A</td>
<td align="left" colspan="1" rowspan="2">LOVD;
<break></break>CentoMD</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1416T.A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">27</td>
<td colspan="1" rowspan="1">Cholestasis, progressive familial
<break></break>intrahepatic 3</td>
<td align="left" colspan="1" rowspan="1">602347</td>
<td align="left" colspan="1" rowspan="1">602347</td>
<td align="left" colspan="1" rowspan="1">ABCB4</td>
<td align="left" colspan="1" rowspan="1">c.2800G&gt;A</td>
<td align="left" colspan="1" rowspan="1">LOVD</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">28</td>
<td colspan="1" rowspan="3">Cholestasis, intrahepatic, of
<break></break>pregnancy, 1</td>
<td align="left" colspan="1" rowspan="3">147480</td>
<td align="left" colspan="1" rowspan="3">147480</td>
<td align="left" colspan="1" rowspan="3">ATP8B1</td>
<td align="left" colspan="1" rowspan="1">c.1286A&gt;C;</td>
<td align="left" colspan="1" rowspan="3">LOVD;
<break></break>CentoMD</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">29</td>
<td colspan="1" rowspan="2">Chondrodysplasia, Grebe type (Grebe
<break></break>Acromesomelic Dysplasia)</td>
<td align="left" colspan="1" rowspan="2">*200700</td>
<td align="left" colspan="1" rowspan="2">200700</td>
<td align="left" colspan="1" rowspan="2">GDF5</td>
<td align="left" colspan="1" rowspan="1">Del G1144;</td>
<td align="left" colspan="1" rowspan="2">16636240</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Transition A1137G</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">30</td>
<td colspan="1" rowspan="2">Chronic granulomatous disease due
<break></break>to deficiency of NCF1</td>
<td align="left" colspan="1" rowspan="2">*233700</td>
<td align="left" colspan="1" rowspan="2">233700</td>
<td align="left" colspan="1" rowspan="2">NCF1</td>
<td align="left" colspan="1" rowspan="1">c.579G&gt;A</td>
<td align="left" colspan="1" rowspan="2">24446915;
<break></break>24446915</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">31</td>
<td colspan="1" rowspan="2">Chronic Granulomatous Disease,
<break></break>X-Linked</td>
<td align="left" colspan="1" rowspan="2">*306400</td>
<td align="left" colspan="1" rowspan="2">306400</td>
<td align="left" colspan="1" rowspan="2">CYBB, XK</td>
<td align="left" colspan="1" rowspan="1">Del gp91-phox gene
<break></break>(CYBB)</td>
<td align="left" colspan="1" rowspan="2">24446915</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">del McLeod gene (XK)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">32</td>
<td colspan="1" rowspan="2">Crigler-Naj ar Syndrome, type II</td>
<td align="left" colspan="1" rowspan="2">606785</td>
<td align="left" colspan="1" rowspan="2">606785</td>
<td align="left" colspan="1" rowspan="2">UGT1A1</td>
<td align="left" colspan="1" rowspan="1">c.211G&gt;A</td>
<td align="left" colspan="1" rowspan="2">9630669</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1456T&gt;G</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">33</td>
<td colspan="1" rowspan="2">Cutis laxa, autosomal recessive,
<break></break>type IIA (with congenital defect of
<break></break>glycosulation)</td>
<td align="left" colspan="1" rowspan="2">*219200</td>
<td align="left" colspan="1" rowspan="2">219200</td>
<td align="left" colspan="1" rowspan="2">ATP6V0A2</td>
<td align="left" colspan="1" rowspan="1">c.294+1G4A</td>
<td align="left" colspan="1" rowspan="2">18157129</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1929delA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="5">34</td>
<td colspan="1" rowspan="5">Cutis laxa, autosomal recessive,
<break></break>type IIIB</td>
<td align="left" colspan="1" rowspan="5">*614438</td>
<td align="left" colspan="1" rowspan="5">614438</td>
<td align="left" colspan="1" rowspan="5">PYCR1</td>
<td align="left" colspan="1" rowspan="1">356G&gt;A</td>
<td align="left" colspan="1" rowspan="5">19648921</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">566C&gt;T</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">356G4A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.356G&gt;A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.566C&gt;T</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">35</td>
<td colspan="1" rowspan="3">Deafness, autosomal recessive 1A</td>
<td align="left" colspan="1" rowspan="3">*220290</td>
<td align="left" colspan="1" rowspan="3">2220290</td>
<td align="left" colspan="1" rowspan="3">GJB2</td>
<td align="left" colspan="1" rowspan="1">S86T</td>
<td align="left" colspan="1" rowspan="2">11748849</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">35delG</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">167delT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">36</td>
<td colspan="1" rowspan="1">Diabetes mellitus, permanent neonatal</td>
<td align="left" colspan="1" rowspan="1">606176</td>
<td align="left" colspan="1" rowspan="1">606176</td>
<td align="left" colspan="1" rowspan="1">ABCC8</td>
<td align="left" colspan="1" rowspan="1">c.4480C&gt;T</td>
<td align="left" colspan="1" rowspan="1">9769320</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="7">37</td>
<td colspan="1" rowspan="7">Dushenne Muscular Dystrophy</td>
<td align="left" colspan="1" rowspan="7">320200</td>
<td align="left" colspan="1" rowspan="7">320200</td>
<td align="left" colspan="1" rowspan="7">DMD</td>
<td align="left" colspan="1" rowspan="1">Del exon 7</td>
<td align="left" colspan="1" rowspan="7">19449031</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dupl exons 55 to 77</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.4996C&gt;T</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1733_1734delTA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1175T &gt; G</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1647T&gt;G;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1521_1523delCTT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">38</td>
<td colspan="1" rowspan="1">Epiphyseal dysplasia, macrocephaly,
<break></break>variable CC agenesis, spindle-shaped
<break></break>fingers, mental retardation</td>
<td align="left" colspan="1" rowspan="1">*226900</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">15q26</td>
<td align="left" colspan="1" rowspan="1">Linkage D15S205/
<break></break>D15S966</td>
<td align="left" colspan="1" rowspan="1">11389160</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">39</td>
<td colspan="1" rowspan="1">Ectodermal dysplasia 1, hypohidrotic,
<break></break>X-linked (EDA)</td>
<td align="left" colspan="1" rowspan="1">305100</td>
<td align="left" colspan="1" rowspan="1">305100</td>
<td align="left" colspan="1" rowspan="1">ED1</td>
<td align="left" colspan="1" rowspan="1">c.G1113A;
<break></break>Gly291Arg</td>
<td align="left" colspan="1" rowspan="1">11279189</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">40</td>
<td colspan="1" rowspan="1">Ectodermal dysplasia 10B,
<break></break>hypohidrotic/hair/tooth type,
<break></break>autosomal recessive</td>
<td align="left" colspan="1" rowspan="1">224900</td>
<td align="left" colspan="1" rowspan="1">224900</td>
<td align="left" colspan="1" rowspan="1">EDAR</td>
<td align="left" colspan="1" rowspan="1">718delAAA</td>
<td align="left" colspan="1" rowspan="1">20979233</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">41</td>
<td colspan="1" rowspan="1">Enhanced S-cone syndrome (Golden-
<break></break>Favre syndrome)</td>
<td align="left" colspan="1" rowspan="1">*268100</td>
<td align="left" colspan="1" rowspan="1">268100</td>
<td align="left" colspan="1" rowspan="1">NR2E3</td>
<td align="left" colspan="1" rowspan="1">c.1117 A&gt;G</td>
<td align="left" colspan="1" rowspan="1">24891813</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">42</td>
<td colspan="1" rowspan="2">Ellis Van-Creveld</td>
<td align="left" colspan="1" rowspan="2">*225500</td>
<td align="left" colspan="1" rowspan="2">225500</td>
<td align="left" colspan="1" rowspan="2">EVC</td>
<td align="left" colspan="1" rowspan="1">Frameshift in exon 13</td>
<td align="left" colspan="1" rowspan="2">17024374;
<break></break>20184732</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">43</td>
<td colspan="1" rowspan="1">Epilepsy, progressive myoclonic 2B
<break></break>(MELF)</td>
<td align="left" colspan="1" rowspan="1">254780</td>
<td align="left" colspan="1" rowspan="1">254780</td>
<td align="left" colspan="1" rowspan="1">NHLRC1</td>
<td align="left" colspan="1" rowspan="1">c.468_469delAG</td>
<td align="left" colspan="1" rowspan="1">18263761</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">44</td>
<td colspan="1" rowspan="1">Escobar syndrome</td>
<td align="left" colspan="1" rowspan="1">*265000</td>
<td align="left" colspan="1" rowspan="1">265000</td>
<td align="left" colspan="1" rowspan="1">CHRNG</td>
<td align="left" colspan="1" rowspan="1">γ78dup(3)</td>
<td align="left" colspan="1" rowspan="1">16826520</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">45</td>
<td colspan="1" rowspan="1">Ethyl Malonic Aciduria</td>
<td align="left" colspan="1" rowspan="1">608451</td>
<td align="left" colspan="1" rowspan="1">608451</td>
<td align="left" colspan="1" rowspan="1">ETHE1</td>
<td align="left" colspan="1" rowspan="1">c.487C&gt;T</td>
<td align="left" colspan="1" rowspan="1">Cento MD;
<break></break>14732903</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">46</td>
<td colspan="1" rowspan="1">Factor X deficiency/Familiar CRM</td>
<td align="left" colspan="1" rowspan="1">*227600</td>
<td align="left" colspan="1" rowspan="1">227600</td>
<td align="left" colspan="1" rowspan="1">F10</td>
<td align="left" colspan="1" rowspan="1">c.381G&gt;A</td>
<td align="left" colspan="1" rowspan="1">12574802</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">47</td>
<td colspan="1" rowspan="2">Fanconi anemia, complementation
<break></break>group D1 (FAD1)</td>
<td align="left" colspan="1" rowspan="2">605724</td>
<td align="left" colspan="1" rowspan="2">605724</td>
<td align="left" colspan="1" rowspan="2">BRCA2</td>
<td align="left" colspan="1" rowspan="1">9609C&gt;T</td>
<td align="left" colspan="1" rowspan="2">22660720</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">exon 25</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">48</td>
<td colspan="1" rowspan="2">Fanconi-Bickel Syndrome (GLUT2)</td>
<td align="left" colspan="1" rowspan="2">138160</td>
<td align="left" colspan="1" rowspan="2">227810</td>
<td align="left" colspan="1" rowspan="2">SLC2A2</td>
<td align="left" colspan="1" rowspan="1">c.1259G&gt;T;</td>
<td align="left" colspan="1" rowspan="2">22660720</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1127T&gt;G</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">49</td>
<td colspan="1" rowspan="1">Familial Mediterranean fever, AR</td>
<td align="left" colspan="1" rowspan="1">*608107</td>
<td align="left" colspan="1" rowspan="1">247100</td>
<td align="left" colspan="1" rowspan="1">MEFV</td>
<td align="left" colspan="1" rowspan="1">c.442G&gt;C</td>
<td align="left" colspan="1" rowspan="1">CentoMD,
<break></break>ClinVar</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4">50</td>
<td colspan="1" rowspan="4">Favism</td>
<td align="left" colspan="1" rowspan="4">305900</td>
<td align="left" colspan="1" rowspan="4">134700</td>
<td align="left" colspan="1" rowspan="4">G6PD</td>
<td align="left" colspan="1" rowspan="1">c.335A&gt;T</td>
<td align="left" colspan="1" rowspan="4">8860013</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G6PD Chatham</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">G6PD A-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2 novel mutations</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">51</td>
<td colspan="1" rowspan="1">Gastrointestinal defects and
<break></break>immunodeficiency syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">243150</td>
<td align="left" colspan="1" rowspan="1">243150</td>
<td align="left" colspan="1" rowspan="1">TTC7A</td>
<td align="left" colspan="1" rowspan="1">Q712X</td>
<td align="left" colspan="1" rowspan="1">25534311</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">52</td>
<td colspan="1" rowspan="2">Geroderma Osteodysplastica
<break></break>Hereditaria</td>
<td align="left" colspan="1" rowspan="2">*231070</td>
<td align="left" colspan="1" rowspan="2">231070</td>
<td align="left" colspan="1" rowspan="2">SCYL1BP1</td>
<td align="left" colspan="1" rowspan="1">C-1_1 :GA&gt;CT;</td>
<td align="left" colspan="1" rowspan="2">18997784</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">257delC</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">53</td>
<td colspan="1" rowspan="1">Geroderma osteodysplastica
<break></break>Hereditatria</td>
<td align="left" colspan="1" rowspan="1">*231070</td>
<td align="left" colspan="1" rowspan="1">231070</td>
<td align="left" colspan="1" rowspan="1">GORAB</td>
<td align="left" colspan="1" rowspan="1">367G-T</td>
<td align="left" colspan="1" rowspan="1">19648921</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4">54</td>
<td colspan="1" rowspan="4">Glaucoma 3A, primary open angle,
<break></break>congenital, juvenile, or adult onset</td>
<td align="left" colspan="1" rowspan="4">*231300</td>
<td align="left" colspan="1" rowspan="4">231300</td>
<td align="left" colspan="1" rowspan="4">CYP1B1</td>
<td align="left" colspan="1" rowspan="1">p.G61E</td>
<td align="left" colspan="1" rowspan="4">1959767</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p.D374N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p.R368H</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p.E229K</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">55</td>
<td colspan="1" rowspan="2">Glycogen Storage Disease II, ACID
<break></break>ALPHA-GLUCOSIDASE DEFICIENCY</td>
<td align="left" colspan="1" rowspan="2">232300</td>
<td align="left" colspan="1" rowspan="2">232300</td>
<td align="left" colspan="1" rowspan="2">GAA</td>
<td align="left" colspan="1" rowspan="1">c.2560C&gt;T</td>
<td align="left" colspan="1" rowspan="2">ClinVar</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.2105G&gt;C;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">56</td>
<td colspan="1" rowspan="1">Griscelli syndrome, type 2</td>
<td align="left" colspan="1" rowspan="1">607624</td>
<td align="left" colspan="1" rowspan="1">607624</td>
<td align="left" colspan="1" rowspan="1">RAB27A</td>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">57</td>
<td colspan="1" rowspan="1">Hemolytic uremic syndrome, atypical,
<break></break>susceptibility to, 3</td>
<td align="left" colspan="1" rowspan="1">612923</td>
<td align="left" colspan="1" rowspan="1">612923</td>
<td align="left" colspan="1" rowspan="1">CFI</td>
<td align="left" colspan="1" rowspan="1">c.1332A&gt;G</td>
<td align="left" colspan="1" rowspan="1">CentoMD</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">58</td>
<td colspan="1" rowspan="1">Hermansky-Pudlak syndrome 2</td>
<td align="left" colspan="1" rowspan="1">608233</td>
<td align="left" colspan="1" rowspan="1">608233</td>
<td align="left" colspan="1" rowspan="1">AP3B1</td>
<td align="left" colspan="1" rowspan="1">c.12_13delTA</td>
<td align="left" colspan="1" rowspan="1">16537806
<break></break>8042664</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">59</td>
<td colspan="1" rowspan="1">Hyperexplexia</td>
<td align="left" colspan="1" rowspan="1">*149400</td>
<td align="left" colspan="1" rowspan="1">149400</td>
<td align="left" colspan="1" rowspan="1">GLRA1</td>
<td align="left" colspan="1" rowspan="1">c.593G&gt;C</td>
<td align="left" colspan="1" rowspan="1">22264702</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="6">60</td>
<td colspan="1" rowspan="6">Hemophagocytic lymphohistiocytosis,
<break></break>familial, 2</td>
<td align="left" colspan="1" rowspan="6">*603553</td>
<td align="left" colspan="1" rowspan="6">603553</td>
<td align="left" colspan="1" rowspan="6">PRF1</td>
<td align="left" colspan="1" rowspan="1">c.265C&gt;A</td>
<td align="left" colspan="1" rowspan="6">17674359</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c. 50delT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.265&gt;A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">.c. 674G&gt;C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.Del12bP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1122G&gt;A/
<break></break>Del12bP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="5">61</td>
<td colspan="1" rowspan="5">Hyperinsulinemic hypoglycemia,
<break></break>familial, 1</td>
<td align="left" colspan="1" rowspan="5">*256450</td>
<td align="left" colspan="1" rowspan="5">256450</td>
<td align="left" colspan="1" rowspan="5">ABCC8</td>
<td align="left" colspan="1" rowspan="1">c.4480C&gt;T</td>
<td align="left" colspan="1" rowspan="5">9769320;
<break></break>25972930</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.96C&gt;A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.563A&gt;G</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.119T&gt;G</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3 novel mutations</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">62</td>
<td colspan="1" rowspan="1">Hyperinsulinemic Hypoglycemia,
<break></break>familiar, 5</td>
<td align="left" colspan="1" rowspan="1">*147670</td>
<td align="left" colspan="1" rowspan="1">609968</td>
<td align="left" colspan="1" rowspan="1">INSR</td>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">63</td>
<td colspan="1" rowspan="1">Hypercholesterolemia, familial</td>
<td align="left" colspan="1" rowspan="1">*143890</td>
<td align="left" colspan="1" rowspan="1">143890</td>
<td align="left" colspan="1" rowspan="1">LDLR</td>
<td align="left" colspan="1" rowspan="1">c.272delG</td>
<td align="left" colspan="1" rowspan="1" valign="top">23162007;
<break></break>24249837</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">64</td>
<td colspan="1" rowspan="1">Hyperlipoproteinemia, type 1D
<break></break>(chylomicronemia)</td>
<td align="left" colspan="1" rowspan="1">*615947</td>
<td align="left" colspan="1" rowspan="1">615947</td>
<td align="left" colspan="1" rowspan="1">GPIHBP1</td>
<td align="left" colspan="1" rowspan="1">C.149G&gt;A</td>
<td align="left" colspan="1" rowspan="1">22106832</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">65</td>
<td colspan="1" rowspan="1">HYPERPHENYLALANINEM IA BH4-
<break></break>deficient C, (HPABH4C)</td>
<td align="left" colspan="1" rowspan="1">*261630</td>
<td align="left" colspan="1" rowspan="1">261630</td>
<td align="left" colspan="1" rowspan="1">QDPR</td>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">66</td>
<td colspan="1" rowspan="1">Hyperoxaluria, primary, type 1</td>
<td align="left" colspan="1" rowspan="1">259900</td>
<td align="left" colspan="1" rowspan="1">259900</td>
<td align="left" colspan="1" rowspan="1">AGXT</td>
<td align="left" colspan="1" rowspan="1">c.33-34insC</td>
<td align="left" colspan="1" rowspan="1">CentoMD;
<break></break>21612638</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">67</td>
<td colspan="1" rowspan="1">Homocystinuria due to MTHFR
<break></break>deficiency</td>
<td align="left" colspan="1" rowspan="1">*236200</td>
<td align="left" colspan="1" rowspan="1">236250</td>
<td align="left" colspan="1" rowspan="1">MTHFR</td>
<td align="left" colspan="1" rowspan="1">het 677C-T</td>
<td align="left" colspan="1" rowspan="1">15053809</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">68</td>
<td colspan="1" rowspan="1">Hypoparathyroidism-retardation-
<break></break>dysmorphism syndrome (Sanhad-
<break></break>Sakati S)</td>
<td align="left" colspan="1" rowspan="1">241410</td>
<td align="left" colspan="1" rowspan="1">241410</td>
<td align="left" colspan="1" rowspan="1">TBCE</td>
<td align="left" colspan="1" rowspan="1">c.155-166del12bp</td>
<td align="left" colspan="1" rowspan="1">19491227</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">69</td>
<td colspan="1" rowspan="1">Hypophosphatasia, childhood</td>
<td align="left" colspan="1" rowspan="1">241510</td>
<td align="left" colspan="1" rowspan="1">241510</td>
<td align="left" colspan="1" rowspan="1">ALPL</td>
<td align="left" colspan="1" rowspan="1">c. 98C&gt;T</td>
<td align="left" colspan="1" rowspan="1">25023282</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">70</td>
<td colspan="1" rowspan="1">Huntington Disease</td>
<td align="left" colspan="1" rowspan="1">143100</td>
<td align="left" colspan="1" rowspan="1">143100</td>
<td align="left" colspan="1" rowspan="1">HTT</td>
<td align="left" colspan="1" rowspan="1">41-54 repeats</td>
<td align="left" colspan="1" rowspan="1">25689972</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">71</td>
<td colspan="1" rowspan="1">HUNTINTON-LIKE DISEASE</td>
<td align="left" colspan="1" rowspan="1">*605613</td>
<td align="left" colspan="1" rowspan="1">NIL</td>
<td align="left" colspan="1" rowspan="1">HIP1R</td>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">72</td>
<td colspan="1" rowspan="2">Ichthyosis, congenital, autosomal
<break></break>recessive 1</td>
<td align="left" colspan="1" rowspan="2">*242300</td>
<td align="left" colspan="1" rowspan="2">242300</td>
<td align="left" colspan="1" rowspan="2">TGM1</td>
<td align="left" colspan="1" rowspan="1">c.278G&gt;A</td>
<td align="left" colspan="1" rowspan="2">23689228</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.396A&gt;H</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">73</td>
<td colspan="1" rowspan="1">Insensivity to pain, congenital, with
<break></break>anhydrosis (HSAN IV)</td>
<td align="left" colspan="1" rowspan="1">256800</td>
<td align="left" colspan="1" rowspan="1">256800</td>
<td align="left" colspan="1" rowspan="1">NTRK1</td>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4">74</td>
<td colspan="1" rowspan="4">Isovaleric acidemia</td>
<td align="left" colspan="1" rowspan="4">*243500</td>
<td align="left" colspan="1" rowspan="4">243500</td>
<td align="left" colspan="1" rowspan="4">IVD</td>
<td align="left" colspan="1" rowspan="1">p.F382fs;</td>
<td align="left" colspan="1" rowspan="4">22960500</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p.R392H;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p.R395Q;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p.E408K</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">75</td>
<td colspan="1" rowspan="1">Jouber Syndrome 1 (JBTS1)</td>
<td align="left" colspan="1" rowspan="1">*213300</td>
<td align="left" colspan="1" rowspan="1">213300</td>
<td align="left" colspan="1" rowspan="1">INPPSE</td>
<td align="left" colspan="1" rowspan="1">c.1546C&gt;T in exon 7</td>
<td align="left" colspan="1" rowspan="1">19668216</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">76</td>
<td colspan="1" rowspan="1">Joubert syndrome 5</td>
<td align="left" colspan="1" rowspan="1">*610142</td>
<td align="left" colspan="1" rowspan="1">610188</td>
<td align="left" colspan="1" rowspan="1">CEP 290</td>
<td align="left" colspan="1" rowspan="1">c.21G&gt;T exone1</td>
<td align="left" colspan="1" rowspan="1">19764032</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">77</td>
<td colspan="1" rowspan="1">Kindler Syndrome (poikiloderma)</td>
<td align="left" colspan="1" rowspan="1">*173650</td>
<td align="left" colspan="1" rowspan="1">173650</td>
<td align="left" colspan="1" rowspan="1">KIND1</td>
<td align="left" colspan="1" rowspan="1">R271X</td>
<td align="left" colspan="1" rowspan="1">12789646</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">78</td>
<td colspan="1" rowspan="1">Leprechaunism</td>
<td align="left" colspan="1" rowspan="1">147670</td>
<td align="left" colspan="1" rowspan="1">246200</td>
<td align="left" colspan="1" rowspan="1">INSR</td>
<td align="left" colspan="1" rowspan="1">Single nucleotide del
<break></break>in exon 10</td>
<td align="left" colspan="1" rowspan="1">OMIM:
<break></break>147670.0028</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">79</td>
<td colspan="1" rowspan="1">Leukodystrophy, hypomyelinating, 2
<break></break>(Pelizaeus-Merzbacher-Like Disease 1)</td>
<td align="left" colspan="1" rowspan="1">*608803</td>
<td align="left" colspan="1" rowspan="1">608804</td>
<td align="left" colspan="1" rowspan="1">GJC2</td>
<td align="left" colspan="1" rowspan="1">c.-20+1G&gt;C</td>
<td align="left" colspan="1" rowspan="1">23143715</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">80</td>
<td colspan="1" rowspan="1">LCHAD deficiency</td>
<td align="left" colspan="1" rowspan="1">600980</td>
<td align="left" colspan="1" rowspan="1">609016</td>
<td align="left" colspan="1" rowspan="1">HADHA</td>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">C</td>
<td colspan="1" rowspan="1">Lipodystrophy, congenital
<break></break>generalized, type 4</td>
<td align="left" colspan="1" rowspan="1">*613327</td>
<td align="left" colspan="1" rowspan="1">613327</td>
<td align="left" colspan="1" rowspan="1">PTRF-Cavin</td>
<td align="left" colspan="1" rowspan="1">c.160delG</td>
<td align="left" colspan="1" rowspan="1">20300641</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">82</td>
<td colspan="1" rowspan="1">Lipodystrophy, congenital
<break></break>generalized, type 1 (BSCL1)</td>
<td align="left" colspan="1" rowspan="1">608594</td>
<td align="left" colspan="1" rowspan="1">608594</td>
<td align="left" colspan="1" rowspan="1">AGPAT2</td>
<td align="left" colspan="1" rowspan="1">Homozygosity
<break></break>D9S1818-DS1826</td>
<td align="left" colspan="1" rowspan="1">11916958</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">83</td>
<td colspan="1" rowspan="1">Lipodystrophy, congenital
<break></break>generalized, type 2 (BSCL2)</td>
<td align="left" colspan="1" rowspan="1">606158</td>
<td align="left" colspan="1" rowspan="1">269700</td>
<td align="left" colspan="1" rowspan="1">SEIPIN</td>
<td align="left" colspan="1" rowspan="1">Homozygocity 1883-
<break></break>4136</td>
<td align="left" colspan="1" rowspan="1">12116229,</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">84</td>
<td colspan="1" rowspan="1">Lipodystrophy, familial partial, 2</td>
<td align="left" colspan="1" rowspan="1">150330</td>
<td align="left" colspan="1" rowspan="1">151660</td>
<td align="left" colspan="1" rowspan="1">LAMIN A\C</td>
<td align="left" colspan="1" rowspan="1">Homozygosity 3757</td>
<td align="left" colspan="1" rowspan="1">12116229</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">85</td>
<td colspan="1" rowspan="1">Limb Girdle muscular dystrophy
<break></break>2B;LGMD2B (Miyoshi myopathy)</td>
<td align="left" colspan="1" rowspan="1">254130</td>
<td align="left" colspan="1" rowspan="1">254130</td>
<td align="left" colspan="1" rowspan="1">DYSF</td>
<td align="left" colspan="1" rowspan="1">C :526C&gt;T</td>
<td align="left" colspan="1" rowspan="1">10469840</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">86</td>
<td colspan="1" rowspan="1">Lissencephaly LIS 4A</td>
<td align="left" colspan="1" rowspan="1">300121</td>
<td align="left" colspan="1" rowspan="1">300121</td>
<td align="left" colspan="1" rowspan="1">DCX</td>
<td align="left" colspan="1" rowspan="1">exon 5:</td>
<td align="left" colspan="1" rowspan="1">11175293</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">87</td>
<td colspan="1" rowspan="1" valign="top">Loeys-Dietz syndrome, type 1</td>
<td align="left" colspan="1" rowspan="1">609192</td>
<td align="left" colspan="1" rowspan="1">609192</td>
<td align="left" colspan="1" rowspan="1">TGFBR1 or 2</td>
<td align="left" colspan="1" rowspan="1">Positive linkage</td>
<td align="left" colspan="1" rowspan="1">16928994</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">88</td>
<td colspan="1" rowspan="1">Long QT syndrome 1(LQT1)</td>
<td align="left" colspan="1" rowspan="1">192500</td>
<td align="left" colspan="1" rowspan="1">192500</td>
<td align="left" colspan="1" rowspan="1">KCNQ1</td>
<td align="left" colspan="1" rowspan="1">1388G&gt;C</td>
<td align="left" colspan="1" rowspan="1">15159330</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">89</td>
<td colspan="1" rowspan="2">MODY type II), Glucokinase related</td>
<td align="left" colspan="1" rowspan="2">*125851</td>
<td align="left" colspan="1" rowspan="2">125891</td>
<td align="left" colspan="1" rowspan="2">GCK</td>
<td align="left" colspan="1" rowspan="1">c.757G&gt;T ;</td>
<td align="left" colspan="1" rowspan="2">24993573</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c. 292C&gt;T;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">90</td>
<td colspan="1" rowspan="1">Mental retardation, autosomal
<break></break>recessive 43 (MRT 43)</td>
<td align="left" colspan="1" rowspan="1">*615817</td>
<td align="left" colspan="1" rowspan="1">615817</td>
<td align="left" colspan="1" rowspan="1">KIAA1033</td>
<td align="left" colspan="1" rowspan="1">c.3056C-G
<break></break>transversion in exon 29</td>
<td align="left" colspan="1" rowspan="1">2149877</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">91</td>
<td colspan="1" rowspan="1">Mental Retardation, autosomal
<break></break>recessive</td>
<td align="left" colspan="1" rowspan="1">*602810</td>
<td align="left" colspan="1" rowspan="1">602810</td>
<td align="left" colspan="1" rowspan="1">HIST 3H3</td>
<td align="left" colspan="1" rowspan="1">c. R130C</td>
<td align="left" colspan="1" rowspan="1">21937992</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">92</td>
<td colspan="1" rowspan="1">Mental Retardation Autosomal
<break></break>Recessive, epilepsy, autism</td>
<td align="left" colspan="1" rowspan="1">*NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">DEAF1</td>
<td align="left" colspan="1" rowspan="1">c.997+4A&gt;C</td>
<td align="left" colspan="1" rowspan="1">26048982</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">93</td>
<td colspan="1" rowspan="1">Meckel Gruber syndrome (MKS 3)</td>
<td align="left" colspan="1" rowspan="1">*607361</td>
<td align="left" colspan="1" rowspan="1">607361</td>
<td align="left" colspan="1" rowspan="1">TMEM67</td>
<td align="left" colspan="1" rowspan="1">c. 383-384AC del</td>
<td align="left" colspan="1" rowspan="1">16415887</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">94</td>
<td colspan="1" rowspan="1">Microcephaly with simplified gyral
<break></break>pattern</td>
<td align="left" colspan="1" rowspan="1">*603807</td>
<td align="left" colspan="1" rowspan="1">603807</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Excluded known loci</td>
<td align="left" colspan="1" rowspan="1">17975804</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">95</td>
<td colspan="1" rowspan="1">Microcephaly 3, primary, autosomal
<break></break>recessive</td>
<td align="left" colspan="1" rowspan="1">604804</td>
<td align="left" colspan="1" rowspan="1">604804</td>
<td align="left" colspan="1" rowspan="1">CDK5RAP2</td>
<td align="left" colspan="1" rowspan="1">c. E234X</td>
<td align="left" colspan="1" rowspan="1">22887808</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">96</td>
<td colspan="1" rowspan="1">Microcephaly 5, primary, autosomal
<break></break>recessive</td>
<td align="left" colspan="1" rowspan="1">608716</td>
<td align="left" colspan="1" rowspan="1">608716</td>
<td align="left" colspan="1" rowspan="1">ASPM</td>
<td align="left" colspan="1" rowspan="1">c.9153_9154 del ins A</td>
<td align="left" colspan="1" rowspan="1">15045028</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">97</td>
<td colspan="1" rowspan="2">Microcephaly and hypomielination</td>
<td align="left" colspan="1" rowspan="2">*Omim 179035</td>
<td align="left" colspan="1" rowspan="2">NA</td>
<td align="left" colspan="1" rowspan="2">PYCR2</td>
<td align="left" colspan="1" rowspan="1">c.355C&gt;T</td>
<td align="left" colspan="1" rowspan="2">25865492</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.751C&gt;T</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">98</td>
<td colspan="1" rowspan="1">Microcephalic osteodysplastic
<break></break>primordial dwarfism, type II</td>
<td align="left" colspan="1" rowspan="1">*210720</td>
<td align="left" colspan="1" rowspan="1">210720</td>
<td align="left" colspan="1" rowspan="1">PCNT</td>
<td align="left" colspan="1" rowspan="1">Maps to 21q22.3</td>
<td align="left" colspan="1" rowspan="1">18174396</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">99</td>
<td colspan="1" rowspan="2">Mucolipidosis IV</td>
<td align="left" colspan="1" rowspan="2">252650</td>
<td align="left" colspan="1" rowspan="2">252650</td>
<td align="left" colspan="1" rowspan="2">MCOLN1</td>
<td align="left" colspan="1" rowspan="1">c.1207C&gt;T</td>
<td align="left" colspan="1" rowspan="2">15523648;
<break></break>11030752;
<break></break>16287144</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Het NM_020533:
<break></break>c.1208G&gt;T.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">100</td>
<td colspan="1" rowspan="1">Mucopolysaccharidosis type IVB
<break></break>(Morquio)</td>
<td align="left" colspan="1" rowspan="1">253010</td>
<td align="left" colspan="1" rowspan="1">252010</td>
<td align="left" colspan="1" rowspan="1">GLB1</td>
<td align="left" colspan="1" rowspan="1">c.1420G&gt;C</td>
<td align="left" colspan="1" rowspan="1">CentoMD</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">101</td>
<td colspan="1" rowspan="1">Multiple endocrine neoplasia IIA
<break></break>(MEN2A)</td>
<td align="left" colspan="1" rowspan="1">171400</td>
<td align="left" colspan="1" rowspan="1">171400</td>
<td align="left" colspan="1" rowspan="1">RET</td>
<td align="left" colspan="1" rowspan="1">c.1900T&gt;C</td>
<td align="left" colspan="1" rowspan="1">8103403</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">102</td>
<td colspan="1" rowspan="2">Menkes Disease (Kinky Hair Disease)</td>
<td align="left" colspan="1" rowspan="2">309400</td>
<td align="left" colspan="1" rowspan="2">309400</td>
<td align="left" colspan="1" rowspan="1">ATP7A</td>
<td align="left" colspan="1" rowspan="2">Novel mutation</td>
<td align="left" colspan="1" rowspan="2">CentoMD</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Xq21.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">103</td>
<td colspan="1" rowspan="1">Multiple pterygium syndrome, lethal
<break></break>type</td>
<td align="left" colspan="1" rowspan="1">*100730</td>
<td align="left" colspan="1" rowspan="1">253290</td>
<td align="left" colspan="1" rowspan="1">CHRNG</td>
<td align="left" colspan="1" rowspan="1">c.ARG448TER</td>
<td align="left" colspan="1" rowspan="1">16826520</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">104</td>
<td colspan="1" rowspan="1">Myotonic Dystrophy 1</td>
<td align="left" colspan="1" rowspan="1">605377</td>
<td align="left" colspan="1" rowspan="1">160900</td>
<td align="left" colspan="1" rowspan="1">DMPK</td>
<td align="left" colspan="1" rowspan="1">Expansion, &gt;rpts
<break></break>1allele</td>
<td align="left" colspan="1" rowspan="1">8036515</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">105</td>
<td colspan="1" rowspan="2">Nephrotic syndrome, type 1</td>
<td align="left" colspan="1" rowspan="2">*256300</td>
<td align="left" colspan="1" rowspan="2">25630</td>
<td align="left" colspan="1" rowspan="2">NPHS1</td>
<td align="left" colspan="1" rowspan="1">(121delCT) ;</td>
<td align="left" colspan="1" rowspan="2">CentoMD;
<break></break>9660941</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.218C&gt;T</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">106</td>
<td colspan="1" rowspan="3">Nephrotic syndrome, type 2, steroid
<break></break>resistant (NPHS2; SRN1)</td>
<td align="left" colspan="1" rowspan="3">*600995</td>
<td align="left" colspan="1" rowspan="3">600995</td>
<td align="left" colspan="1" rowspan="3">NPHS2</td>
<td align="left" colspan="1" rowspan="1">c.467Dup/c.709G&gt;;</td>
<td align="left" colspan="1" rowspan="3">CentoMD;
<break></break>15817495</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.709G&gt;C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.779T&gt;A;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">107</td>
<td colspan="1" rowspan="1">Noonan syndrome 1 (NS1)</td>
<td align="left" colspan="1" rowspan="1">163150</td>
<td align="left" colspan="1" rowspan="1">163150</td>
<td align="left" colspan="1" rowspan="1">PTPN11</td>
<td align="left" colspan="1" rowspan="1">c.218C&gt;T</td>
<td align="left" colspan="1" rowspan="1">12161469</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">108</td>
<td colspan="1" rowspan="1">Niemann-Pick disease, type C1
<break></break>(NPC1)</td>
<td align="left" colspan="1" rowspan="1">*257220</td>
<td align="left" colspan="1" rowspan="1">257220</td>
<td align="left" colspan="1" rowspan="1">NPC1</td>
<td align="left" colspan="1" rowspan="1">c.3362T&gt;G</td>
<td align="left" colspan="1" rowspan="1">Cento MD</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">109</td>
<td colspan="1" rowspan="2">Osteogenesis imperfecta, type VIII</td>
<td align="left" colspan="1" rowspan="2">610915</td>
<td align="left" colspan="1" rowspan="2">610915</td>
<td align="left" colspan="1" rowspan="2">LEPRE1</td>
<td align="left" colspan="1" rowspan="1">c.2075-1G&gt;A</td>
<td align="left" colspan="1" rowspan="2">24498616;
<break></break>LOVD</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1170+9G&gt;A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">110</td>
<td colspan="1" rowspan="1">Osteogenesis imperfecta, type VI</td>
<td align="left" colspan="1" rowspan="1">613982</td>
<td align="left" colspan="1" rowspan="1">613982</td>
<td align="left" colspan="1" rowspan="1">SERPINF1</td>
<td align="left" colspan="1" rowspan="1">c.-9+2dup</td>
<td align="left" colspan="1" rowspan="1">23054245</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">111</td>
<td colspan="1" rowspan="1">Osteopetrosis, infantilile malignant</td>
<td align="left" colspan="1" rowspan="1">*259700</td>
<td align="left" colspan="1" rowspan="1">259700</td>
<td align="left" colspan="1" rowspan="1">TCIRG1</td>
<td align="left" colspan="1" rowspan="1">c.-XY_-YZdel</td>
<td align="left" colspan="1" rowspan="1">23685543</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">112</td>
<td colspan="1" rowspan="1">Orofaciodigital syndrome V</td>
<td align="left" colspan="1" rowspan="1">*174300</td>
<td align="left" colspan="1" rowspan="1">174300</td>
<td align="left" colspan="1" rowspan="1">DDX59</td>
<td align="left" colspan="1" rowspan="1">c.1600G&gt;A</td>
<td align="left" colspan="1" rowspan="1">23972372</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">113</td>
<td colspan="1" rowspan="2">Paroxysmal nonkinesigenic dyskinesia
<break></break>(PNKD1)</td>
<td align="left" colspan="1" rowspan="2">*118800</td>
<td align="left" colspan="1" rowspan="2">118800</td>
<td align="left" colspan="1" rowspan="2">MR-1 gene</td>
<td align="left" colspan="1" rowspan="1">c.20C&gt;T : A7V ;</td>
<td align="left" colspan="1" rowspan="2">16632198</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.26C&gt;T : A9V)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">114</td>
<td colspan="1" rowspan="1">Peroxisome biogenesis disorder 1A
<break></break>(Zellweger)</td>
<td align="left" colspan="1" rowspan="1">602136</td>
<td align="left" colspan="1" rowspan="1">214100</td>
<td align="left" colspan="1" rowspan="1">PEX-1</td>
<td align="left" colspan="1" rowspan="1">c.1927_1928dupA;. c.
<break></break>2088A&gt;G</td>
<td align="left" colspan="1" rowspan="1">PMCID:
<break></break>2649967;
<break></break>25407003</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">115</td>
<td colspan="1" rowspan="1">Pelger-Huet anomaly</td>
<td align="left" colspan="1" rowspan="1">*169400</td>
<td align="left" colspan="1" rowspan="1">169400</td>
<td align="left" colspan="1" rowspan="1">LBR</td>
<td align="left" colspan="1" rowspan="1">del 6 BP in splice site
<break></break>intron 12</td>
<td align="left" colspan="1" rowspan="1">21326950</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">116</td>
<td colspan="1" rowspan="3" valign="top">Pheochromosytoma/paraganglioma 4</td>
<td align="left" colspan="1" rowspan="3" valign="top">115310</td>
<td align="left" colspan="1" rowspan="3" valign="top">115310</td>
<td align="left" colspan="1" rowspan="3" valign="top">SDHB</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.771dup.A;</td>
<td align="left" colspan="1" rowspan="3" valign="top">25034258;
<break></break>15328326</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.574T&gt;C;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.859G&gt;A;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">117</td>
<td colspan="1" rowspan="1">Pituitary hormone deficiency,
<break></break>combined, 3</td>
<td align="left" colspan="1" rowspan="1">*221750</td>
<td align="left" colspan="1" rowspan="1">221750</td>
<td align="left" colspan="1" rowspan="1">LHX3</td>
<td align="left" colspan="1" rowspan="1">3,088-bp deletion</td>
<td align="left" colspan="1" rowspan="1">18407919</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">118</td>
<td colspan="1" rowspan="1">Pontocerebellar Hypoplasia type III</td>
<td align="left" colspan="1" rowspan="1">*608027</td>
<td align="left" colspan="1" rowspan="1">608027</td>
<td align="left" colspan="1" rowspan="1">PCLO</td>
<td align="left" colspan="1" rowspan="1">nonsense mutation of
<break></break>
<italic>PCLO</italic> (
<italic>piccolo</italic>) gene</td>
<td align="left" colspan="1" rowspan="1">25832664</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">119</td>
<td colspan="1" rowspan="1">Polycystic Kidney and Hepatic
<break></break>Disease 1</td>
<td align="left" colspan="1" rowspan="1">263200</td>
<td align="left" colspan="1" rowspan="1">263200</td>
<td align="left" colspan="1" rowspan="1">FCYT</td>
<td align="left" colspan="1" rowspan="1">c.107C&gt;T</td>
<td align="left" colspan="1" rowspan="1">11919560</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">120</td>
<td colspan="1" rowspan="1">Polycystic liver disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">608648</td>
<td align="left" colspan="1" rowspan="1">608648</td>
<td align="left" colspan="1" rowspan="1">SEC63</td>
<td align="left" colspan="1" rowspan="1">Del in promoter
<break></break>region</td>
<td align="left" colspan="1" rowspan="1">24886261
<break></break> 25165181</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">121</td>
<td colspan="1" rowspan="1">Rabson-Mendenhall syndrome</td>
<td align="left" colspan="1" rowspan="1">262190</td>
<td align="left" colspan="1" rowspan="1">262190</td>
<td align="left" colspan="1" rowspan="1">INSR</td>
<td align="left" colspan="1" rowspan="1">c.671_685dup</td>
<td align="left" colspan="1" rowspan="1">CentoMD;
<break></break>22824672</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">122</td>
<td colspan="1" rowspan="1">Rajab Syndrome</td>
<td align="left" colspan="1" rowspan="1">*613658</td>
<td align="left" colspan="1" rowspan="1">613658</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">linkage D2S351/
<break></break>D2S2390</td>
<td align="left" colspan="1" rowspan="1">19161147</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">123</td>
<td colspan="1" rowspan="2">Renal tubular acidosis, distal, AR, with
<break></break>hemolitic anaemia</td>
<td align="left" colspan="1" rowspan="2">*611590</td>
<td align="left" colspan="1" rowspan="2">611590</td>
<td align="left" colspan="1" rowspan="2">SLC4A1</td>
<td align="left" colspan="1" rowspan="1">A858D;</td>
<td align="left" colspan="1" rowspan="2">22126643</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">A858D/N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">124</td>
<td colspan="1" rowspan="1">Retinitis pigmentosa-12, autosomal
<break></break>recessive</td>
<td align="left" colspan="1" rowspan="1">*604210</td>
<td align="left" colspan="1" rowspan="1">600105</td>
<td align="left" colspan="1" rowspan="1">RABS 1</td>
<td align="left" colspan="1" rowspan="1">7 mutations</td>
<td align="left" colspan="1" rowspan="1">24512366</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">125</td>
<td colspan="1" rowspan="1">Retinitis pigmentosa 37</td>
<td align="left" colspan="1" rowspan="1">*604485</td>
<td align="left" colspan="1" rowspan="1">268100</td>
<td align="left" colspan="1" rowspan="1">NR2E3</td>
<td align="left" colspan="1" rowspan="1">p.D406G</td>
<td align="left" colspan="1" rowspan="1">24891813</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">126</td>
<td colspan="1" rowspan="1">Rett Syndrome</td>
<td align="left" colspan="1" rowspan="1">312750</td>
<td align="left" colspan="1" rowspan="1">312750</td>
<td align="left" colspan="1" rowspan="1">MECP2</td>
<td align="left" colspan="1" rowspan="1">c.880C&gt;T</td>
<td align="left" colspan="1" rowspan="1">ClinVar</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">127</td>
<td colspan="1" rowspan="2">Robinow syndrome, autosomal
<break></break>recessive</td>
<td align="left" colspan="1" rowspan="2">*268310</td>
<td align="left" colspan="1" rowspan="2">268310</td>
<td align="left" colspan="1" rowspan="2">ROR 2</td>
<td align="left" colspan="1" rowspan="1">c.1504C&gt;T</td>
<td align="left" colspan="1" rowspan="2">10932186;
<break></break>19640924</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.1324C&gt;T</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">128</td>
<td colspan="1" rowspan="1">Severe combined immunodeficiency,
<break></break>B cell-negative</td>
<td align="left" colspan="1" rowspan="1">179615</td>
<td align="left" colspan="1" rowspan="1">601457</td>
<td align="left" colspan="1" rowspan="1">RAG1</td>
<td align="left" colspan="1" rowspan="1">c.1187G&gt;A</td>
<td align="left" colspan="1" rowspan="1">ClinVar</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">129</td>
<td colspan="1" rowspan="2">Spinal Muscular Atrophy (SMN1)</td>
<td align="left" colspan="1" rowspan="2">253300</td>
<td align="left" colspan="1" rowspan="2">253300</td>
<td align="left" colspan="1" rowspan="2">SMN1</td>
<td align="left" colspan="1" rowspan="1">del exons 5, 6, 8 ;</td>
<td align="left" colspan="1" rowspan="2">15000810;
<break></break>17940251</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Del 5q13.2 in exon 7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">130</td>
<td colspan="1" rowspan="1">Spastic paraplegia 18, autosomal
<break></break>recessive (IDMDC)</td>
<td align="left" colspan="1" rowspan="1">*611225</td>
<td align="left" colspan="1" rowspan="1">611225</td>
<td align="left" colspan="1" rowspan="1">ERLIN 2</td>
<td align="left" colspan="1" rowspan="1">(D8S1820 and
<break></break>D8S532)</td>
<td align="left" colspan="1" rowspan="1">16636240</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">131</td>
<td colspan="1" rowspan="1">Spastic paraplegia 20, SPG20; (Troyer
<break></break>Syndrome)</td>
<td align="left" colspan="1" rowspan="1">*275900</td>
<td align="left" colspan="1" rowspan="1">275900</td>
<td align="left" colspan="1" rowspan="1">SPG 20</td>
<td align="left" colspan="1" rowspan="1">c.123X</td>
<td align="left" colspan="1" rowspan="1">20437587</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">132</td>
<td colspan="1" rowspan="1">Spastic paraplegia 35, autosomal
<break></break>recessive; (FAHN); Leukodystrophy,
<break></break>dysmyelinating, and spastic
<break></break>paraparesis</td>
<td align="left" colspan="1" rowspan="1">612319</td>
<td align="left" colspan="1" rowspan="1">612319</td>
<td align="left" colspan="1" rowspan="1">FA2H</td>
<td align="left" colspan="1" rowspan="1">c.235A&gt;C</td>
<td align="left" colspan="1" rowspan="1">20104589</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">133</td>
<td colspan="1" rowspan="1">Spastic paraplegia 54, autosomal
<break></break>recessive</td>
<td align="left" colspan="1" rowspan="1">*615033</td>
<td align="left" colspan="1" rowspan="1">615003.0005</td>
<td align="left" colspan="1" rowspan="1">DDHD2</td>
<td align="left" colspan="1" rowspan="1">1546C-T transition</td>
<td align="left" colspan="1" rowspan="1">23176823</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">134</td>
<td colspan="1" rowspan="1">Spastic paraplegia, ataxia, and
<break></break>mental retardation</td>
<td align="left" colspan="1" rowspan="1">*607565</td>
<td align="left" colspan="1" rowspan="1">607565</td>
<td align="left" colspan="1" rowspan="1">GRID2</td>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">135</td>
<td colspan="1" rowspan="1">Split-hand/foot malformation with long
<break></break>bone deficiency 3</td>
<td align="left" colspan="1" rowspan="1">*612576</td>
<td align="left" colspan="1" rowspan="1">612576</td>
<td align="left" colspan="1" rowspan="1">BHLHA9</td>
<td align="left" colspan="1" rowspan="1">microduplications</td>
<td align="left" colspan="1" rowspan="1">22147889</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">136</td>
<td colspan="1" rowspan="1">Spondylometaepiphyseal dysplasia,
<break></break>short limb-hand type (SMED-SL)</td>
<td align="left" colspan="1" rowspan="1">*271665</td>
<td align="left" colspan="1" rowspan="1">271665</td>
<td align="left" colspan="1" rowspan="1">DDR2</td>
<td align="left" colspan="1" rowspan="1">c.2468_2469del CT</td>
<td align="left" colspan="1" rowspan="1">24725993</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">137</td>
<td colspan="1" rowspan="1">Spondyloepiphyseal dysplasia Omani
<break></break>type with congenital joint dislocations</td>
<td align="left" colspan="1" rowspan="1">*143095</td>
<td align="left" colspan="1" rowspan="1">1439095</td>
<td align="left" colspan="1" rowspan="1">CHST3</td>
<td align="left" colspan="1" rowspan="1">c. 911G&gt;A</td>
<td align="left" colspan="1" rowspan="1">15215498</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">138</td>
<td colspan="1" rowspan="1">Spondylocostal dysostosis 2,
<break></break>autosomal recessive</td>
<td align="left" colspan="1" rowspan="1">605915</td>
<td align="left" colspan="1" rowspan="1">608681</td>
<td align="left" colspan="1" rowspan="1">MESP2;</td>
<td align="left" colspan="1" rowspan="1">c.880C&gt;T</td>
<td align="left" colspan="1" rowspan="1">ClinVar</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">139</td>
<td colspan="1" rowspan="1">Spinocerebellar ataxia 7;
<break></break>Olivopontocerebellar atrophy III;
<break></break>ADCA type II</td>
<td align="left" colspan="1" rowspan="1">164500</td>
<td align="left" colspan="1" rowspan="1">164500</td>
<td align="left" colspan="1" rowspan="1">ATXN7;</td>
<td align="left" colspan="1" rowspan="1">Repeat expansion of
<break></break>ATXN7 gene</td>
<td align="left" colspan="1" rowspan="1">ClinVar</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">140</td>
<td colspan="1" rowspan="1">Schwartz-Jampel syndrome, type 1</td>
<td align="left" colspan="1" rowspan="1">*255800</td>
<td align="left" colspan="1" rowspan="1">255800</td>
<td align="left" colspan="1" rowspan="1">HSPG-2</td>
<td align="left" colspan="1" rowspan="1">IVS64DS, A-G, +4;
<break></break>c.1532C&gt;T</td>
<td align="left" colspan="1" rowspan="1">11101850</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">141</td>
<td colspan="1" rowspan="2">Stuve-Wiedemann syndrome/
<break></break>Schwartz-Jampel type 2 syndrome</td>
<td align="left" colspan="1" rowspan="2">601559</td>
<td align="left" colspan="1" rowspan="2">601559</td>
<td align="left" colspan="1" rowspan="2">LIFR</td>
<td align="left" colspan="1" rowspan="1">c.653_654insT</td>
<td align="left" colspan="1" rowspan="2">14740318</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.643del T;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">142</td>
<td colspan="1" rowspan="1">Systemic Lupus Erythematosus (SLE),
<break></break>susceptibility.</td>
<td align="left" colspan="1" rowspan="1">*125505</td>
<td align="left" colspan="1" rowspan="1">152700</td>
<td align="left" colspan="1" rowspan="1">DNASE1L3</td>
<td align="left" colspan="1" rowspan="1">G38OR ;</td>
<td align="left" colspan="1" rowspan="1">22019780</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">143</td>
<td colspan="1" rowspan="2">Thanatophoric Dysplasia type 1</td>
<td align="left" colspan="1" rowspan="2">*187600</td>
<td align="left" colspan="1" rowspan="2">187600</td>
<td align="left" colspan="1" rowspan="2">FGFR-3</td>
<td align="left" colspan="1" rowspan="1">R248C</td>
<td align="left" colspan="1" rowspan="2">12633765</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.4406A&gt;G</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">144</td>
<td colspan="1" rowspan="2">Three-M syndrome 1</td>
<td align="left" colspan="1" rowspan="2">*273750</td>
<td align="left" colspan="1" rowspan="2">273750</td>
<td align="left" colspan="1" rowspan="2">CUL</td>
<td align="left" colspan="1" rowspan="1">c2434C&gt;T</td>
<td align="left" colspan="1" rowspan="1">19225462</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">690 ins C</td>
<td align="left" colspan="1" rowspan="1">19877176</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">145</td>
<td colspan="1" rowspan="1">Three M Syndrome 2</td>
<td align="left" colspan="1" rowspan="1">*610991</td>
<td align="left" colspan="1" rowspan="1">612921</td>
<td align="left" colspan="1" rowspan="1">OBCL1</td>
<td align="left" colspan="1" rowspan="1">844ins68</td>
<td align="left" colspan="1" rowspan="1">19877176</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">146</td>
<td colspan="1" rowspan="1">Thrombosis, hyperhomocysteinemic</td>
<td align="left" colspan="1" rowspan="1">*236200</td>
<td align="left" colspan="1" rowspan="1">236200</td>
<td align="left" colspan="1" rowspan="1">CBS</td>
<td align="left" colspan="1" rowspan="1">c.807C&gt;A;</td>
<td align="left" colspan="1" rowspan="1">16432849</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">147</td>
<td colspan="1" rowspan="2">Thyroid hormone resistance,
<break></break>autosomal recessive</td>
<td align="left" colspan="1" rowspan="2">190160</td>
<td align="left" colspan="1" rowspan="2">274300</td>
<td align="left" colspan="1" rowspan="2">TRB2</td>
<td align="left" colspan="1" rowspan="1">del in exon10</td>
<td align="left" colspan="1" rowspan="1">1991834</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">148</td>
<td colspan="1" rowspan="1">von Hippel-Lindau syndrome (VHL)</td>
<td align="left" colspan="1" rowspan="1">*193300</td>
<td align="left" colspan="1" rowspan="1">193300</td>
<td align="left" colspan="1" rowspan="1">VHL</td>
<td align="left" colspan="1" rowspan="1">Novel mutation</td>
<td align="left" colspan="1" rowspan="1">NA</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The disorders are listed in alphabetical order along with the mutations detected in Omani patients. Novel genes and/or mutations identified for the first time in Omani nationals are marked by an asterisk (*). Unpublished mutation data referred as “Novel mutations” would be updated following publication, currently source stated as “NA”.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T3" orientation="portrait" position="anchor">
<label>Table 3. </label>
<caption>
<title>Mutations associated with hemoglobin disorders in the Omani population.</title>
</caption>
<table content-type="article-table" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Disease</th>
<th align="left" colspan="1" rowspan="1">OMIM</th>
<th align="left" colspan="1" rowspan="1">Gene/Locus</th>
<th align="left" colspan="1" rowspan="1">Nucleotide change</th>
<th align="left" colspan="1" rowspan="1">PMID</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="10">Sickle cell anemia/
<break></break>Hemoglobin variants</td>
<td align="left" colspan="1" rowspan="10">603903</td>
<td align="left" colspan="1" rowspan="10">HBB</td>
<td align="left" colspan="1" rowspan="1">c.19G&gt;A</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.20A&gt;T</td>
<td align="left" colspan="1" rowspan="1">81926</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.92G&gt;C</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.97C&gt;G</td>
<td align="left" colspan="1" rowspan="1">1517102</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.79G&gt;A</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.176C&gt;A</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.176C&gt;G</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.364G&gt;A</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.364G&gt;C</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.389C&gt;T</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="23">Beta Thalassemia</td>
<td align="left" colspan="1" rowspan="23">613985</td>
<td align="left" colspan="1" rowspan="23">HBB</td>
<td align="left" colspan="1" rowspan="1">c.-151C&gt;T</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.-138C&gt;A</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.-121C&gt;T*</td>
<td align="left" colspan="1" rowspan="1">21801233</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.-102G&gt;T*</td>
<td align="left" colspan="1" rowspan="1">25826385</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.17_18delCT</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.27_28insG</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.32C&gt;T</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.47G&gt;A</td>
<td align="left" colspan="1" rowspan="1">20353347</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.51delC</td>
<td align="left" colspan="1" rowspan="1">20353347</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.90C&gt;T</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.92G&gt;A</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.92+1G&gt;A</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.92+5G&gt;C</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.92+6T&gt;C</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.93-22_95del</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.93-21G&gt;A</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.93-3T&gt;G</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.118C&gt;T</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.126_129delCTTT</td>
<td align="left" colspan="1" rowspan="1">20353347</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.135delC</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.315+1G&gt;A</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.316-2A&gt;G</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.*108_*112delAATAA</td>
<td align="left" colspan="1" rowspan="1">25677748</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="22">Alpha Thalassemia</td>
<td align="left" colspan="1" rowspan="22">604131</td>
<td align="left" colspan="1" rowspan="22">HBA1/HBA2</td>
<td align="left" colspan="1" rowspan="1">c.24G&gt;C</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.38C&gt;A</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.43T&gt;C</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.55G&gt;C</td>
<td align="left" colspan="1" rowspan="1">24165563</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.56G&gt;A</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.56delG</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.64G&gt;C;</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.71A&gt;T</td>
<td align="left" colspan="1" rowspan="1">5675637</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.95+2_c.95+6delTGAGG</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.118_120delACC</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.181A&gt;G</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.264C&gt;G</td>
<td align="left" colspan="1" rowspan="1">25826385</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.283_300+3dup*</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.326C&gt;A</td>
<td align="left" colspan="1" rowspan="1">16840225</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.427T&gt;C</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.*92A&gt;G</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.*94A&gt;G</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hybrid 3.7 -5 (C&gt;T)*</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hybrid 3.7 +46 (C&gt;A)*</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- -(MED-I); deletion of ~17.5 kb including
<break></break>both alpha-globin genes</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3.7 kb deletion</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4.2 kb deletion</td>
<td align="left" colspan="1" rowspan="1">25370869</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="14">Delta Thalassemia</td>
<td align="left" colspan="1" rowspan="14">142000</td>
<td align="left" colspan="1" rowspan="14">HBD</td>
<td align="left" colspan="1" rowspan="1">c.-118C&gt;T</td>
<td align="left" colspan="1" rowspan="1">24985928</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.14C&gt;T</td>
<td align="left" colspan="1" rowspan="1">24985928</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.49G&gt;C</td>
<td align="left" colspan="1" rowspan="1">24985928</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.68C&gt;A</td>
<td align="left" colspan="1" rowspan="1">6058951</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.82G&gt;T</td>
<td align="left" colspan="1" rowspan="1">24985928</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.93-1G&gt;C</td>
<td align="left" colspan="1" rowspan="1">24985928</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.295G&gt;A</td>
<td align="left" colspan="1" rowspan="1">2477064</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.301C&gt;T</td>
<td align="left" colspan="1" rowspan="1">24985928</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.333-334insGT*</td>
<td align="left" colspan="1" rowspan="1">24985928</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.350G&gt;A</td>
<td align="left" colspan="1" rowspan="1">24985928</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.410G&gt;A</td>
<td align="left" colspan="1" rowspan="1">24985938</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.422C&gt;T</td>
<td align="left" colspan="1" rowspan="1">17145605</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.427G&gt;C*</td>
<td align="left" colspan="1" rowspan="1">25043855</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c.443G&gt;T*</td>
<td align="left" colspan="1" rowspan="1">24985928</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The different mutations reported by the National Genetic Center in patients with Hemoglobinopathies in Oman. Novel mutations are indicated by an asterisk (*) indicated to the left side of the mutation. Mutations are listed in ascending order based on nucleotide position.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>For the majority (85%) of rare disorders presented in
<xref ref-type="table" rid="T2">Table 2</xref>, data was derived from publications. The original mutations identified for the first time in Omani population constitute more than half of rare disease data presented in
<xref ref-type="table" rid="T2">Table 2</xref>.</p>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Soon after the completion of the Human Genome Project in 2003, it was clear that the genetic data collected until then presented only a glimpse of the complexity of the human genome and the significance of genetic variants in human disease. Since then, genetic researchers have unearthed innumerable variants that are not only individual-specific; but also ethnicity-, population- and country-specific. Human genetic variation databases have significant implications for both diagnostic and predictive medicine. Often, the pathogenicity of rare mutations is primarily assessed through multiple reports of occurrence in diseased patients that are documented and routinely updated in mutation databases. Given the fact that gene mutations and their frequencies in many Mendelian disorders differ widely between different ethnic groups, even within a country, national databases are highly valuable resources for studies on disease-gene associations, population diversity and genetic history
<sup><xref ref-type="bibr" rid="ref-10">10</xref></sup>.</p>
<p>The catalog of Omani mutations presented here will therefore represent a valuable resource that may guide mutation analysis in Omanis suspected of having genetic disease. Unique circumstances in Oman with government-funded comprehensive healthcare throughout the country, and the national coverage for clinical genetics has made the present study possible. Future efforts will be required to extend this database to cover the full spectrum of mutations and population specific variants.</p>
<p>The disease-associated mutation data presented (
<xref ref-type="table" rid="T1">Table 1</xref>,
<xref ref-type="table" rid="T2">Table 2</xref>,
<xref ref-type="table" rid="T3">Table 3</xref>) show a considerable proportion of novel disease genes as well as novel genetic variants within the Omani population. This was expected due to the presence of inbred and geographically isolated communities, the practice of consanguineous marriages, all of which have tended to skew the allelic spectrum toward rare and private variants within the Omani population. In addition to this, the list of genetic variants also reveals known mutations that were previously reported in certain non-Omani populations, thereby reflecting the historic genetic admixture that occurred in Oman, along the trade routes of a once powerful Omani empire and its foreign colonies. Many of the mutations reported are unique to the Omani population, suggesting a founder effect.</p>
<p>The interest in genetic testing is growing among physicians aiming to provide better medical care and genetic disease prevention. The data collected largely represent mutations of rare autosomal recessively inherited disorders in Oman. The mutation data in
<xref ref-type="table" rid="T2">Table 2</xref> can be searched by OMIM number, or by disease name. The names of diseases in
<xref ref-type="table" rid="T2">Table 2</xref> were chosen as described in OMIM in “Phenotype-Gene Relationships” table as “Phenotype” in order to ease finding specific genetic disorders by name.</p>
<p>The number of collected mutations among different disease groups (
<xref ref-type="table" rid="T1">Table 1</xref>) reflect the frequency of disorders in the Omani population, the burden caused by genetic diseases
<sup><xref ref-type="bibr" rid="ref-4">4</xref></sup>, and the interests of individual clinicians in genetic testing.</p>
<p>The knowledge of the genetics of Hemoglobin disorders is among the best in Oman due to national preventive programs and research starting from the 1990s. It is not surprising that around a third of all mutations known in Omani population to date are in four genes causing Hemoglobin disorders (
<xref ref-type="table" rid="T1">Table 1</xref>,
<xref ref-type="table" rid="T3">Table 3</xref>). The birth prevalence of infants with a hemoglobin disorder was recorded as 3.5–4.7/1,000
<sup><xref ref-type="bibr" rid="ref-7">7</xref>,
<xref ref-type="bibr" rid="ref-11">11</xref></sup>. The frequency of hemoglobin disorders in Oman is among the highest in the world, and may reflect natural selection due to advantage for survival, in the heterozygous state, against malaria. Around 10% of Omani nationals are carriers of the allele for sickle cell anemia, 2–3% carry an allele for Beta-thalassemia and 45% are carriers of an alpha-thalassemia allele
<sup><xref ref-type="bibr" rid="ref-12">12</xref>–
<xref ref-type="bibr" rid="ref-15">15</xref></sup>.</p>
<p>Genetic disorders causing disabilities and handicap are of great concern. These are different groups of rare disorders leading to intellectual disability or physical handicap requiring detailed clinical classification, genetic testing, research and preventive measures. The high prevalence of birth defects and genetic conditions in Omani communities causes social, psychological and financial difficulties
<sup><xref ref-type="bibr" rid="ref-4">4</xref></sup>. The development and use of national mutation data is of importance to Omani medical care because it not only allows the genetic burden of disease to be quantified, but also provides diagnosticians and researchers access to an up-to-date resource that will assist them in their daily clinical practice and biomedical research
<sup><xref ref-type="bibr" rid="ref-9">9</xref></sup>. National databases for genetic variants are also significant from the perspective of preventive healthcare. There is a significant correlation between the occurrence of rare genetic variants associated with Mendelian disease and the burden of morbidity from complex diseases within a population. Heterozygous carriers for recessive disease genes do not manifest the recessive disease but may be at risk of developing complex trait conditions with some similarity in phenotype. For example, heterozygote carriers of mutations in the ataxia telangiectasia gene locus are reportedly susceptible to breast cancer
<sup><xref ref-type="bibr" rid="ref-16">16</xref></sup>, and heterozygote carriers of mutations in the glucocerebrosidase (
<italic>GBA</italic>) gene causing Gaucher disease are at an increased risk for Parkinson disease
<sup><xref ref-type="bibr" rid="ref-17">17</xref>,
<xref ref-type="bibr" rid="ref-18">18</xref></sup>. Hence, the collection of genetic variant data in national databases will contribute significantly to the prevention of genetic diseases in the population and might greatly impact the management of complex trait diseases in the future. Genetic scientists and international consortiums studying human genetic variation are increasingly interested in dissecting the interplay between genetic makeup and environmental influences on the pattern of diseases worldwide. Current research is expected to create a foundation for the national data online for the benefit of Oman Healthcare.</p>
</sec>
<sec>
<title>Data availability</title>
<p>This article was prepared to introduce the first Omani genetic variation database. This data is available online at
<ext-link ext-link-type="uri" xlink:href="HTTP://ogvd.net">HTTP://ogvd.net</ext-link>; raw datasets are not available for Royal Hospital laboratory and clinical data, as the registry contains confidential information that could not be deidentified.</p>
</sec>
</body>
<back>
<ref-list>
<ref id="ref-1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tadmouri</surname><given-names>GO</given-names></name><name><surname>Al Ali</surname><given-names>MT</given-names></name><name><surname>Al Khaja</surname><given-names>N</given-names></name></person-group>:
<article-title>Genetic disorders in Arab World: Oman</article-title>. Publication of Center for Arab Genomic Studies, Dubai.<year>2008</year>;<volume>3</volume>
<ext-link ext-link-type="uri" xlink:href="http://www.cags.org.ae/publications/details.aspx?id=7">Reference Source</ext-link>
</mixed-citation>
</ref>
<ref id="ref-2">
<label>2</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Rajab</surname><given-names>A</given-names></name></person-group>:
<article-title>Genetic Disorders in Oman</article-title>. In: Teebi AS (ed):
<italic>Genetic Disorders Among Arab Populations.</italic>Berlin: Springer,<year>2010</year>;<fpage>473</fpage>–<lpage>490</lpage>.
<pub-id pub-id-type="doi">10.1007/978-3-642-05080-0_16</pub-id>
</mixed-citation>
</ref>
<ref id="ref-3">
<label>3</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Rajab</surname><given-names>A</given-names></name><name><surname>Patton</surname><given-names>M</given-names></name></person-group>:
<article-title>Genetic diseases in the Sultanate of Oman</article-title>. In: Dhavendra Kumar (ed.),
<italic>Genomics and health in the developing world; Oxford monograph on medical genetics</italic> Oxford University Press,<year>2012</year>;<fpage>678</fpage>–<lpage>693</lpage>.
<pub-id pub-id-type="doi">10.1093/med/9780195374759.003.0054</pub-id>
</mixed-citation>
</ref>
<ref id="ref-4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rajab</surname><given-names>A</given-names></name><name><surname>Al Salmi</surname><given-names>Q</given-names></name><name><surname>Jaffer</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Congenital and genetic disorders in the Sultanate of Oman. First attempt to assess healthcare needs.</article-title>
<source/><italic>J Community Genet.</italic>
<year>2014</year>;<volume>5</volume>(<issue>3</issue>):<fpage>283</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1007/s12687-014-0182-4</pub-id>
<!--<pub-id pub-id-type="pmcid">4059850</pub-id>-->
<pub-id pub-id-type="pmid">24585275</pub-id></mixed-citation>
</ref>
<ref id="ref-5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rajab</surname><given-names>A</given-names></name><name><surname>Bappal</surname><given-names>B</given-names></name><name><surname>Al-Shaikh</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Common autosomal recessive diseases in Oman derived from a hospital-based registry.</article-title>
<source/><italic>Community Genet.</italic>
<year>2005</year>;<volume>8</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1159/000083334</pub-id>
<pub-id pub-id-type="pmid">15767751</pub-id></mixed-citation>
</ref>
<ref id="ref-6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Thihli</surname><given-names>K</given-names></name><name><surname>Al-Murshedi</surname><given-names>F</given-names></name><name><surname>Al-Hashmi</surname><given-names>N</given-names></name><etal></etal></person-group>:
<article-title>Consanguinity, endogamy and inborn errors of metabolism in Oman: a cross-sectional study.</article-title>
<source/><italic>Hum Hered.</italic>
<year>2014</year>;<volume>77</volume>(<issue>1–4</issue>):<fpage>183</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1159/000362686</pub-id>
<pub-id pub-id-type="pmid">25060282</pub-id></mixed-citation>
</ref>
<ref id="ref-7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rajab</surname><given-names>A</given-names></name><name><surname>Patton</surname><given-names>MA</given-names></name></person-group>:
<article-title>Analysis of the population structure in Oman.</article-title>
<source/><italic>Community Genet.</italic>
<year>1999</year>;<volume>2</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>5</lpage>.
<pub-id pub-id-type="doi">10.1159/000016179</pub-id>
<pub-id pub-id-type="pmid">15178958</pub-id></mixed-citation>
</ref>
<ref id="ref-8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rajab</surname><given-names>A</given-names></name><name><surname>Al Rashdi</surname><given-names>I</given-names></name><name><surname>Al Salmi</surname><given-names>Q</given-names></name></person-group>:
<article-title>Genetic services and testing in the Sultanate of Oman. Sultanate of Oman steps into modern genetics.</article-title>
<source/><italic>J Community Genet.</italic>
<year>2013</year>;<volume>4</volume>(<issue>3</issue>):<fpage>391</fpage>–<lpage>397</lpage>.
<pub-id pub-id-type="doi">10.1007/s12687-013-0153-1</pub-id>
<!--<pub-id pub-id-type="pmcid">3739849</pub-id>-->
<pub-id pub-id-type="pmid">23821042</pub-id></mixed-citation>
</ref>
<ref id="ref-9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patrinos</surname><given-names>GP</given-names></name><name><surname>Smith</surname><given-names>TD</given-names></name><name><surname>Howard</surname><given-names>H</given-names></name><etal></etal></person-group>:
<article-title>Human Variome Project country nodes: documenting genetic information within a country.</article-title>
<source/><italic>Hum Mutat.</italic>
<year>2012</year>;<volume>33</volume>(<issue>11</issue>):<fpage>1513</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1002/humu.22147</pub-id>
<pub-id pub-id-type="pmid">22753370</pub-id></mixed-citation>
</ref>
<ref id="ref-10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patrinos</surname><given-names>GP</given-names></name><name><surname>Cooper</surname><given-names>DN</given-names></name><name><surname>van Mulligen</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>Microattribution and nanopublication as means to incentivize the placement of human genome variation data into the public domain.</article-title>
<source/><italic>Hum Mutat.</italic>
<year>2012</year>;<volume>33</volume>(<issue>11</issue>):<fpage>1503</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1002/humu.22144</pub-id>
<pub-id pub-id-type="pmid">22736453</pub-id></mixed-citation>
</ref>
<ref id="ref-11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rajab</surname><given-names>A</given-names></name><name><surname>Patton</surname><given-names>MA</given-names></name></person-group>:
<article-title>Major factors determining the frequencies of hemoglobinopathies in Oman</article-title>. Letter to the Editor.
<source/><italic>Am J Med Genet.</italic>
<year>1997</year>;<volume>71</volume>(<issue>2</issue>):<fpage>240</fpage>–<lpage>242</lpage>.
<pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19970808)71:2&lt;240::AID-AJMG26&gt;3.0.CO;2-D</pub-id>
<pub-id pub-id-type="pmid">9217233</pub-id></mixed-citation>
</ref>
<ref id="ref-12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alkindi</surname><given-names>S</given-names></name><name><surname>Al Zadjali</surname><given-names>S</given-names></name><name><surname>Al Madhani</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates.</article-title>
<source/><italic>Hemoglobin.</italic>
<year>2010</year>;<volume>34</volume>(<issue>2</issue>):<fpage>135</fpage>–<lpage>44</lpage>.
<pub-id pub-id-type="doi">10.3109/03630261003677213</pub-id>
<pub-id pub-id-type="pmid">20353348</pub-id></mixed-citation>
</ref>
<ref id="ref-13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>White</surname><given-names>JM</given-names></name><name><surname>Christie</surname><given-names>BS</given-names></name><name><surname>Nam</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Frequency and clinical significance of erythrocyte genetic abnormalities in Omanis.</article-title>
<source/><italic>J Med Genet.</italic>
<year>1993</year>;<volume>30</volume>(<issue>5</issue>):<fpage>396</fpage>–<lpage>400</lpage>.
<pub-id pub-id-type="doi">10.1136/jmg.30.5.396</pub-id>
<!--<pub-id pub-id-type="pmcid">1016376</pub-id>-->
<pub-id pub-id-type="pmid">8320702</pub-id></mixed-citation>
</ref>
<ref id="ref-14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daar</surname><given-names>S</given-names></name><name><surname>Hussein</surname><given-names>HM</given-names></name><name><surname>Merghoub</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>Spectrum of beta-thalassemia mutations in Oman.</article-title>
<source/><italic>Ann N Y Acad Sci.</italic>
<year>1998</year>;<volume>850</volume>:<fpage>404</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1749-6632.1998.tb10504.x</pub-id>
<pub-id pub-id-type="pmid">9668567</pub-id></mixed-citation>
</ref>
<ref id="ref-15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daar</surname><given-names>S</given-names></name><name><surname>Hussain</surname><given-names>HM</given-names></name><name><surname>Gravell</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Genetic epidemiology of HbS in Oman: multicentric origin for the β
<sup>S</sup> gene.</article-title>
<source/><italic>Am J Hematol.</italic>
<year>2000</year>;<volume>64</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>46</lpage>.
<pub-id pub-id-type="doi">10.1002/(SICI)1096-8652(200005)64:1&lt;39::AID-AJH7&gt;3.0.CO;2-%23</pub-id>
<pub-id pub-id-type="pmid">10815786</pub-id></mixed-citation>
</ref>
<ref id="ref-16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Athma</surname><given-names>P</given-names></name><name><surname>Rappaport</surname><given-names>R</given-names></name><name><surname>Swift</surname><given-names>M</given-names></name></person-group>:
<article-title>Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer.</article-title>
<source/><italic>Cancer Genet Cytogenet.</italic>
<year>1996</year>;<volume>92</volume>(<issue>2</issue>):<fpage>130</fpage>–<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.1016/S0165-4608(96)00328-7</pub-id>
<pub-id pub-id-type="pmid">8976369</pub-id></mixed-citation>
</ref>
<ref id="ref-17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goker-Alpan</surname><given-names>O</given-names></name><name><surname>Schiffmann</surname><given-names>R</given-names></name><name><surname>LaMarca</surname><given-names>ME</given-names></name><etal></etal></person-group>:
<article-title>Parkinsonism among Gaucher disease carriers.</article-title>
<source/><italic>J Med Genet.</italic>
<year>2004</year>;<volume>41</volume>(<issue>12</issue>):<fpage>937</fpage>–<lpage>40</lpage>.
<pub-id pub-id-type="doi">10.1136/jmg.2004.024455</pub-id>
<!--<pub-id pub-id-type="pmcid">1735652</pub-id>-->
<pub-id pub-id-type="pmid">15591280</pub-id></mixed-citation>
</ref>
<ref id="ref-18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sidransky</surname><given-names>E</given-names></name><name><surname>Samaddar</surname><given-names>T</given-names></name><name><surname>Tayebi</surname><given-names>N</given-names></name></person-group>:
<article-title>Mutations in
<italic>GBA</italic> are associated with familial Parkinson disease susceptibility and age at onset.</article-title>
<source/><italic>Neurology.</italic>
<year>2009</year>;<volume>73</volume>(<issue>17</issue>):<fpage>1424</fpage>–<lpage>5</lpage>, author reply 1425–6.
<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181b28601</pub-id>
<pub-id pub-id-type="pmid">19858467</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
<sub-article article-type="peer-review" id="report10729">
<front-stub>
<article-id pub-id-type="doi">10.5256/f1000research.7471.r10729</article-id>
<title-group>
<article-title>Referee response for version 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dogra</surname>
<given-names>Shaillay</given-names>
</name>
<xref ref-type="aff" rid="r10729a1">1</xref>
<role>Referee</role>
</contrib>
<aff id="r10729a1">
<label>1</label>Vishuo BioMedical Pte Ltd, Singapore, Singapore</aff>
</contrib-group>
<author-notes>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>10</month>
<year>2015</year>
</pub-date>
<related-article ext-link-type="doi" id="d35e4930" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.6938.1">Version 1</related-article>
<custom-meta-group>
<custom-meta>
<meta-name>recommendation</meta-name>
<meta-value>approve</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>Its useful to have region/country specific databases that present a better representation of the prevalence and incidence of region specific diseases and health issues. Putting such data in context of whats known globally shall help in better interpreting whats peculiar to local population and possibly raise some interesting questions on why so? For example, is it the genetic structure or something in the environment?</p>
<p>Some specific comments follow:
<list list-type="order"><list-item><p>Authors mention existence of tribal structures, consanguineous marriages etc in Omani society. Is it possible to delineate the effects of these factors on the reported mutations? For example, is this reported in the papers that the authors have collated data from and have the authors noted this aspect in their database?</p></list-item><list-item><p>How does the mutation data reported here compare with mutation patterns or frequency seen in other populations? Do the authors provide information on this or link out to other similar resources from other countries? If a physician in Oman is looking up some mutation from this database and wants to know if this is something specific to Oman or is a more general mutation found in other populations too, would this information appear automatically in the database; or could they perform a manual search of the database?</p></list-item><list-item><p>Do the authors want to comment about any data privacy issues that maybe associated with such a database, if any and to what extent?</p></list-item><list-item><p>Are there any attributes on quality of data in the database? perhaps based on the technique used in the original paper or some other measure some quality metric can be assigned to the mutation information recorded in the database?</p></list-item><list-item><p>It would be helpful if authors were able to illustrate out a case or two on how they expect a doctor in Oman to be able to use this database in a real clinical setting; to illustrate the usefulness of the database from a simple collection of data to something that can be used on a more regular basis by doctors in clinical setting.</p></list-item></list>
</p>
<p>I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
</body>
</sub-article>
<sub-article article-type="peer-review" id="report10505">
<front-stub>
<article-id pub-id-type="doi">10.5256/f1000research.7471.r10505</article-id>
<title-group>
<article-title>Referee response for version 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ranganath</surname>
<given-names>Prajnya</given-names>
</name>
<xref ref-type="aff" rid="r10505a1">1</xref>
<role>Referee</role>
</contrib>
<aff id="r10505a1">
<label>1</label>Department of Medical Genetics, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India</aff>
</contrib-group>
<author-notes>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests: </bold>No competing interests were disclosed.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>9</day>
<month>10</month>
<year>2015</year>
</pub-date>
<related-article ext-link-type="doi" id="d35e4998" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.6938.1">Version 1</related-article>
<custom-meta-group>
<custom-meta>
<meta-name>recommendation</meta-name>
<meta-value>approve</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<list list-type="order"><list-item><p>The paper is well-written and though it does not present any new findings, it can be used as a reference database for Omani mutations.</p></list-item><list-item><p>There are a few suggestions for the authors:</p><p>a. Standard HGVS nomenclature should be followed for all the mutations and the authors should preferably stick to one format i.e. either DNA or protein notation. There is no uniformity in the present nomenclature followed in Table 2.</p><p>b. Number of patients in whom each mutation was found, should be indicated – this would give an idea about any preponderance of specific mutations in this population.</p><p>c. Functional validation studies, if available, or at least the mutation prediction scores should be mentioned for the novel sequence variants identified, which will help create a comprehensive database of new likely-pathogenic variants. Again, if the number of patients in whom each of these novel variants were identified is mentioned, we will get an idea as to whether these novel variants were present in more than one case and we can get further proof of the pathogenicity of these mutations.</p><p>d. It would also be interesting to see if there is any ethnic group-wise preponderance of genetic diseases or mutations in the various subsets/ tribes/ regional groups that constitute the Omani population.</p></list-item></list>
</p>
<p>I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
</body>
</sub-article>
</article>
</pmc-articleset>